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SUMMARY 
 
Over the past years, Salmonella Enteritidis (SE) has become the most prevalent serovars 
isolated in Canadian patients. Most cases in humans are associated with consumption of 
chicken meat, raw egg and related products. For controlling Salmonella transmission and 
infection in poultry, available commercially killed vaccines poorly stimulate mucosal 
immunity, while the use of live vaccines remains controversial. Therefore an oral subunit 
vaccine may be a solution. Five bacterial proteins were chosen as potential candidates and 
identified as Glyceraldehyde-3-phosphate dehydrogenase, Enolase, Lipoamide dehydrogenase, 
DNA protection during starvation protein and Elongation factor-Tu.  Our objectives were to 
produce and purify these proteins and study their immunogenicity. The proteins genes were 
amplified and cloned into pQE-30 vector, then transformed into Escherichia coli M15 for 
expression. Purification was performed using FPLC. SPF laying hens were separated into 6 
groups and injected intramuscularly 3 times at 16, 20 and 28 weeks of age. Five groups were 
injected with a single protein respectively while the sixth group was injected with PBS as 
control. Eggs were collected during the duration of the experiment and blood was collected 
when hens were sacrificed at 36 weeks of age. IgY was extracted from egg yolk and serum 
and IgA from egg white. Immunodot, westernblot and ELISA were used to evaluate the 
immunogenicity of proteins and antibody levels they induced. We found that these five 
proteins could stimulate production of specific antibody in vivo. GAPDH, Enolase and DPS 
induced higher antibody titer than LpdA and Ef-Tu. 
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RÉSUMÉ 
 
Au cours des dernières années, Salmonella Enteritidis est devenus les sérotypes les plus 
souvent isolés chez les patients canadiens, les cas étant liés à la consommation de viande de 
poulet et d’œufs crus. Les vaccins tués commercialement disponibles pour la volaille, 
stimulent mal l'immunité mucosale, tandis que l'utilisation de vaccins vivants reste 
controversée. Par conséquent, un vaccin sous-unitaire par voie orale peut être une solution. 
Cinq protéines bactériennes ont été choisies comme candidates potentielles et identifiées, soit 
Glyceraldehyde-3-phosphate dehydrogenase, Enolase, Lipoamide dehydrogenase, DNA 
protection during starvation protein et Elongation factor-Tu. Notre objectif a été de produire et 
de purifier ces protéines et de démontrer leur immunogénicité. Les gènes des protéines ont été 
amplifiés et clonés dans le vecteur pQE-30 pour expression dans Escherichia coli M15. La 
purification a été effectuée par FPLC. Des poules pondeuses SPF ont été séparées en 6 
groupes et injectées par voie intramusculaire à different âges avec une des 5 protéines, ou le 
PBS chez le groupe témoin. Les œufs ont été ramassés pendant l'expérience et du sang a été 
prélevé à 36 semaines d'âge. Les anticorps IgY ont été extraits à partir du jaune d'oeuf et du 
sérum, et les IgA à partir du blanc d'oeuf. Des immunodots, westernblots et ELISA ont évalué 
l'immunogénicité des protéines et les niveaux d'anticorps induits . Nous avons constaté que ces 
cinq protéines pourraient stimuler la production d'anticorps spécifiques in vivo. GAPDH, 
Enolase et DPS ont induit des titres d'anticorps plus élevés que LpdA et EF-Tu. 
 
Mots-clés : SE, ST, vaccin, poule, IgY, IgA, ELISA 
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Salmonella spp. is one of the major causes of foodborne illnesses in humans, which remains a 
worldwide problem. Over the past years, the most prevalent serovars isolated in Canadian 
patients were Salmonella Enteritidis (SE) (CIPARS, 2007-2009). Human SE cases are most 
commonly associated with the consumption of contaminated eggs, egg products and more 
recently with poultry meat. For Salmonella infection in chickens, we have observed an 
increase in the prevalence of SE in samples from abattoir, retail meat and animal clinical 
isolates (CIPARS, 2007-2009). The Canadian egg industry has over the past years developed 
several programs to detect and limit SE contamination. However, even with good biosecurity 
protocols and various controlling programs, breeder and layer flocks still become infected 
with SE and can transmit it horizontally and vertically. In order to prevent SE contamination, 
vaccination has been suggested and various killed vaccines are commercially available. 
Although they were able to induce an immune response, these vaccines did not protect SE 
challenged hens from excreting the bacteria and even laying positive SE eggs at 55 and 65 
weeks of age (Tran et al., 2010). In fact, the cell-mediated response appears to play an 
important role in the resolution of Salmonella infection, presumably because Salmonella is an 
intracellular facultative pathogen. Unfortunately, commercially available killed vaccines 
poorly stimulate mucosal immunity, and live vaccine use remains controversial due to risk of 
virulence recovery and food safety concerns. Another vaccine strategy is the development of 
sub-unit vaccine orally administered using protein antigens. Thus subunit vaccine may then 
induce efficient stimulation of mucosal immune system to protect birds from Salmonella.  
 
For this project, five candidate proteins have been chosen in our lab from previous work, 
based on their immune reactions to SE and ST whole-cell antigens as well as well 
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conservation in both Salmonella serovars. Their cell-surface expression and immunogenicity 
were also reported in other different species in different precious researches. These 5 proteins 
were identified as Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), Enolase, 
Lipoamide dehydrogenase (LpdA), DNA protection during starvation protein (Dps) and 
Elongation factor-Tu (EF-Tu). In this project, based on biological and immunological 
characters of these selected proteins, we have the hypothesis: these proteins are immunogenic 
and able to induce immune responses in laying hens and antibody production in both sera and 
eggs (yolk and white). Our main objectives are to produce and demonstrate the 
immunogenicity of these immunoreactive proteins, with the ultimate objective of eventually 
developing a new subunit vaccine against Salmonella Enteritidis and Salmonella 
Typhimurium in laying and breeder hens. For the protein production, we need to use an 
optimal method to purify these proteins effectively once they are overexpressed in E.coli M15 
cells, in order to ensure the satisfactory quality and purity of produced proteins. After 
production of these selected proteins, we will test if each protein is immunogenic i.e., able to 
induce specific antibody in vivo (as measured in eggs and sera) after immunization laying hens 
with each of them. If these proteins are demonstrated to be immunogenic to be capable of 
inducing specific antibody production, we will continue to have a closer look at specific 
antibody titer levels and changes post vaccination and maintenance of blood, egg yolk and egg 
white antibody titers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LITERATURE REVIEW 
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1 GENERAL INTRODUCTION OF SALMONELLA 
 
Salmonellosis is an important zoonotic infection, and human salmonellosis causes widespread 
morbidity and economic loss. In recent years, some countries have observed a marked increase 
in the number of human cases (Hendriksen et al., 2011). Much of this increase has been 
associated with poultry meat and table eggs consumption (Foley et al., 2011). The 
predominance of Salmonella Enteritidis as a human pathogen has overshadowed other 
Salmonella serovars, many of which are capable of causing serious illness such as Salmonella 
Typhimurium DT 104 (Bohaychuk et al., 2006; Foley et al., 2008; Foley et al., 2011).  
 
The economic losses associated with human salmonellosis are not only associated with the 
cost of investigations, treatment, and prevention of illness but also may affect the whole chain 
of food production. Estimated annual costs for salmonellosis might have reached billions of 
dollars in the United States and Canada in the 1990s only (Sockett, 1991; Clark et al., 2001). 
 
Although primarily an intestinal bacteria, Salmonella is widespread in the environment and is 
commonly found in farm effluents, human sewage, and in any material subject to fecal 
contamination. Salmonellosis has been recognized in all countries, especially in the areas of 
intensive animal husbandry, such as poultry and swine production (Berends et al., 1996; 
Akkina et al., 1999). Although disease can affect all species of domestic animals, young and 
gestation animals are the most susceptible. However, most infected animals are asymptomatic 
carriers i.e. are infected without showing any sign of illness. The challenge in the food animal 
industry resides not only in the detection of these asymptomatic carriers to avoid 
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contamination of the food chain, but also mostly in preventing animals to becoming infected. 
Vaccination could therefore be an important tool in a prevention and control program. 
 
1.1 Classification of Salmonella 
 
Salmonella is a genus of rod-shaped, Gram-negative, non-spore-forming, predominantly 
motile enterobacteria with diameters around 0.7 to 1.5 µm, lengths from 2 to 5 µm, and 
flagella which grade in all directions (i.e., peritrichous). They are chemoorganotrophs, 
obtaining their energy from oxidation and reduction reactions using organic sources, and are 
facultative anaerobes. Most Salmonella produce hydrogen sulfide that is important for 
bacteriological isolation (Clark and Barrett, 1987). They are found worldwide in cold- and 
warm-blooded animals (including humans), and in the environment (Yue, 2012). 
 
Genus Salmonella includes two species: Salmonella bongori and Salmonella enterica. 
Salmonella enterica is subdivided into 6 subspecies (enterica, salamae, arizonae, diarizonae, 
houtenae and indica).  Salmonella enterica subspecies enterica has 2610 different serotypes 
and Salmonella Enteritidis belongs to this subspecies, The serotypes are characterized by three 
surface antigens: the flagella “H” antigen, the oligosaccharide “O” antigen and the 
polysaccharide “Vi” antigen (found in Typhi and Paratyphi serotypes) (Bronze and Greenfield, 
2005). 
 
Salmonella serovars can be divided into two groups, those that are host adapted and others that 
are not. Host-adapted serovars are able to cause diseases in specific hosts, including S. typhi 
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and the paratyphoid Salmonellae (S. paratyphi A, S. paratyphi B, and S. paratyphi C) for 
human, and S. Choleraesuis (swine), S. Dublin (cattle), S. Abortusovis (sheep), S. Pullorum 
(poultry) and S. Gallinarum (poultry) for animals (Barrow, 1992; Selander et al., 1992; Bolton 
et al., 1999; Uzzau et al., 2001).  On the other hand, non-host-specific Salmonella serovars 
cause salmonellosis in humans and a wide variety of animal hosts as well. Salmonella enterica 
serovar Enteritidis (SE) belongs to this group, and have presented serious continuous 
challenge in food safety and poultry industry over the past years being responsible for 
significant health problems in human (Mølbak et al., 2006). 
 
1.2 Prevalence of Salmonella 
 
1.2.1 Prevalence in human 
 
Salmonella is considered as one of the most common foodborne illness etiologic agent in 
human. In a recent CDC (Centers for Disease Control and Prevention) summary of USA, 
Salmonella Enteritidis (SE) was described as the most prevalent serotype responsible for 
17.5% of all human salmonellosis (CDC, 2009). In the EU, SE is the serovar most frequently 
associated with human illness. In 2008, a total of 131,468 confirmed cases of human 
salmonellosis (notification rate 26.4 per 100,000 populations) were reported from 27 European 
countries. The total number of reported human salmonellosis cases in the EU has decreased 
steadily by several thousand cases annually since 2004, from 195,947 cases in 2004 to 
133,258 cases in 2008 (EFSA, 2008). In 2009, the number of salmonellosis cases in humans 
decreased by 17.4 %, compared to 2008, and the statistically significant decreasing trend in 
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the European Union continued for the fifth consecutive year. In total 108,614 confirmed 
human cases were reported in 2009 and in particular, human cases caused by SE decreased 
markedly.  It is assumed that the observed reduction of salmonellosis cases is mainly 
attributed to successful implementation of national Salmonella control programs in poultry 
(EFSA, 2009). 
 
In Canada, from 2005 to 2010, Salmonella accounted for the most frequent cases in human 
when comparing with other foodborne pathogens, which include Campylobacter, E. coli, 
Shigella, Vibrio, etc. Based on the latest NESP (National Enteric Surveillance Program) 
annual report (2010), in all provinces of Canada, including Quebec, Salmonella caused much 
more human cases than other select major organism groups as (NESP Annual Summary, 
2010). Among all the serovars of Salmonella, SE was one of the most important public health 
concerns. From 2005 to 2010, the ranking among the top three serovars remained unchanged 
with SE being the most frequently reported, followed by ST and Salmonella Heidelberg, 
(NESP Annual Summary, 2010). PT8 and PT13 were the predominant phage types found in 
human SE (CIPARS Annual Report, 2008). 
 
In 2010 a record high of 2827 SE isolations were reported to NESP. SE was the most 
prevalent cause of human salmonellosis in Canada representing approximately 39% of all 
human Salmonella isolates reported in 2010. The proportion of salmonellosis cases attributed 
to SE has been steadily increasing over time, from 14% in 2000 to 39% in 2010 (Figure 1).  
 
Figure 1. Incidence rate of Salmonella spp. and SE as reported to NESP from 2000 to 
2010 (NESP Annual Summary, 2010). 
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1.2.2 Prevalence in chickens 
 
In United States, the presence of SE was identified in 35% of layer flocks (end of laying 
period) from cecal sample collected in Northern US slaughterhouses between 1991 and 1995 
(Ebel and Schlosser, 2000). The prevalence of environmental contamination in SE was 7.1% 
for 200 laying hens’ farms in 15 states (Garber et al. 2003). Meanwhile, the high percentage of 
samples positive for SE was detected in ground chickens (0.46%, 8/1722 samples) and broilers 
(0.26%, 124/47090 samples) (White et al. 2007). In 2010, CDC investigated a multistate 
outbreak of SE infections in the United States, and a total of 3,578 cases in humans were 
identified from May 1 to November 30, 2010. According to the data from the investigations 
conducted by public health official in 11 states, the shell eggs were a likely source of this huge 
outbreak. Certain egg suppliers and farms conducted a nationwide egg recall after the outbreak 
was reported (CDC, 2010). This was the largest egg recall in American history. Throughout 
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the whole country, more than 500 million eggs were involved in the nationwide recall (FDA, 
2010). Total costs to American shell-egg producers is not clear yet, however, the negative 
media attention produced a drop in prices that cost the shell-egg industry over $100 million in 
September 2010 only (Capturing Recall Costs Measuring and Recovering the Losses. 2011.).  
 
In Europe, SE was one of the most predominant serotypes detected in laying hens and their 
eggs in 2008. Over the past 20 to 25 years, SE has been frequently isolated from 
environmental samples of egg-laying flocks when compared to other isolates of other 
serotypes (EFSA, 2007). The prevalence of SE and ST in laying flocks has increased from 
0.5% (2005) to 2.3% (2006) and 3.2% (2007) (EFSA. 2009), even with the nations control 
programs in place. The EU has passed legislation that requires member states to actively work 
to reduce the presence of Salmonella in poultry flocks at all levels of production by setting up 
national control programs that must target specific Salmonella serovars (most regulations 
currently only cover SE and ST). This has resulted in a significant decrease in the prevalence 
of SE in broiler, layer and breeding flocks since 2008 (Keery, 2010). 
 
In Canada, SE has become the third most important Salmonella serovar from chicken sources 
including samples from abattoir and retail meat, while the isolation rate, which was less than 
1% in 2002, increasing to 7% in 2006 (CIPARS annual report, 2006; PHAC, 2007). SE 
isolated from chicken fecal samples has also increased sharply over the past five years, going 
from just less than 1% in 2002 to 13% in 2006 in the samples collected at slaughter (PHAC, 
2007). In parallel, the increase has also been observed in broilers with successive increases 
observed over the last 3 years (2006: 20% 2007: 30% 2008: 40% percentage cultures positive) 
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(Middleton, 2009). In Canada, in 2008, in an abattoir surveillance program, Salmonella 
isolates were recovered from 27% (234/851) from chicken cecal samples, in which the SE was 
the second most common serovar (19%, 45/234) following Salmonella Kentucky (40%, 
93/234). In Canadian retail meat surveillance, Salmonella isolates were recovered from 40% 
(382/960) of retail chicken samples, in which Kentucky (31%, 120/382), Heidelberg (20%, 
78/382) and Enteritidis (16%, 62/382) were most frequent serovars. Also in 2008, in the 
province of Quebec, Salmonella was present in 42% (120/287) of retail chicken samples, and 
Salmonella Enteritidis was the third most prevalent (16%, 62/382) compared to all other 
serovars. Regarding surveillance of animal clinical isolates, including layer hens, broiler 
chickens, and their environment, the most common Salmonella serovar was Enteritidis, 
accounting 47% of all the 209 Salmonella isolates (CIPARS, 2008). 
 
1.3 Source of Salmonella 
 
1.3.1 Sources of animal infection 
 
Poultry may acquire Salmonella infection from various sources, including parent birds, 
feedstuffs, rodents, wild birds, and other vehicles. 
 
Wild animals provide a Salmonella reservoir, and are consequently a potential source for 
transmission of infection to domestic animals. Birds of all species, rodents, foxes, badgers, and 
other animals have been shown to be sources of Salmonella (Edel et al., 1976; Euden, 1990; 
Evans and Davies, 1996). Insects, such as litter beetles and flies, have been observed to be risk 
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factors for the re-introduction of Salmonella into poultry houses after depopulating, cleaning 
and restocking the premises (Davies and Wray, 1995). 
 
Henzler and Opitz (1991) demonstrated that the most important vectors of Salmonella 
transmission are rodents, especially mice. In 1992, they tested 2103 environmental samples 
and 715 mice and rats from five of the farms were rated as clean of SE and five as 
contaminated based on culture results of environmental samples for SE. On contaminated 
farms, SE was isolated from 24.0% of the mice and 7.5% of the environmental samples, which 
represented 75.3% of all Salmonella isolations from mice but only 18.0% of Salmonella 
isolations from environmental samples on these farms. SE was not detected in mice on clean 
farms. Rodents can be long-term sources of Salmonella infection: it was found that 3-week-old 
chicks can acquire infection via mice artificially infected with SE 2 and 5 months previously. 
Artificially and naturally infected rodents were found to excrete 104–106 cfu/g in some 
individual droppings; while their droppings can be contaminated for up to 3 months post 
infection (Meerburg and Kijlstra, 2007). So it suggested that rodents should be included in all 
epizootiological studies of poultry production facilities as a risk factor.  
 
Salmonella can contaminate feed, which is a potential source of Salmonella in animals 
entering the food chain (Guard-Petter 2001). When the feed is contaminated with the bacteria, 
the birds will get infected and potentially introduce Salmonella to the whole flock or their 
offspring. When infected birds defecate in open water drinkers, they will contaminate the 
drinking water. The open water suppliers are also easy to be contaminated by dust, rodents and 
other wild animals when they contact the water source.  
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Humans (such as farm staff, veterinarians, and visitors) and domesticated animals (such as 
cats and dogs) can also serve as vectors of Salmonella introduction into food animal flocks 
(Kinde et al., 2005; Hoelzer et al., 2011). Moreover, Salmonella may also be transmitted by 
airborne spread of aerosols from, for instance, manure, human waste dumps and contaminated 
water (Hardman et al., 1991; Zongo et al., 2010; Henrigues et al., 2013). Moreover, 
contaminated working cloths and boots, cages and vehicles will cause potential cross 
contaminations between flocks, hatchery, and even chicken farms. 
 
In addition, the presence of large amount of dust in poultry houses may also be a risk. Indeed 
dust has been recognized as a vehicle of transmission of Salmonella when large numbers of 
organisms are present and it could cause infection in flocks (Harbaugh et al., 2006). 
 
Once chickens get infected with the organisms in the surrounding environment, in addition to 
contaminate other birds, the bacteria will be excreted with feces and the infection will exist in 
reproductive organs and tracts as well. Egg might be infected either via its formation process 
in reproductive tracts or via penetration of bacteria in the feces through the egg shell, and the 
infection in the egg will be transmitted to offspring at last (Gantois et al., 2009). 
Environmental contamination in hatcheries also can be a key factor of egg contamination 
(Skov et al., 1999). Nest boxes, hatchers or hatchery trucks can lead to outer shell 
contamination (Schoeni et al, 1995). Contaminated eggshells have long been thought to lead 
to the spread of Salmonella in the hatchery (Cox et al., 2000). Cox et al. (1990, 1991) found 
that breeder and broiler hatcheries were highly contaminated with Salmonella. In the broiler 
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hatchery, this contamination was detected on 71% of eggshell fragments, 80% of chick 
conveyor belt swab samples, and 74% of samples of pads placed under newly hatched chicks 
to gather feces (Cox et al., 2000). The presence of chicken manure and other moist organic 
materials facilitate the survival and growth of Salmonella by providing the required nutrients 
and physical protection (Gantois 2009). 
 
1.3.2 Sources of human infection 
 
Human most commonly gets Salmonella via ingestion of contaminated food. Food products 
derived from raw or undercooked eggs and poultry meat are the most important sources for 
human infection with Salmonella. Chicken carcasses may contain Salmonella either because 
animals are infected or because they were in contact with contaminated feces as well as 
possible cross-contamination from the slaughter or transport equipment during processing 
(Salmonella Surveillance: Annual Summary, 2006; Rasschaert et al., 2008). 
 
Unpasteurized milk and beef can be the common vehicles of food-borne infection too, and 
other foods cross-contaminated during preparation, storage or serving may be involved as 
well. An increase numbers of infections have also occurred following ingestion of 
contaminated uncooked vegetables, fruits, etc (Barak et al, 2005). Pork and pork products are 
also increasingly recognized as an important source of human salmonellosis (Jansen et al., 
2007). Moreover, direct or indirect contact with animals colonized with Salmonella is 
considered to be another source of infection, including contact during visits to petting zoos 
and farms (Friedman et al., 1998). Recently, turtles were reported as an important source of 
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Salmonella in humans, especially in children, and have caused several outbreaks in USA in 
2012 (CDC, 2013). This has led to stricter regulations regarding the sales of these reptiles in 
pet shops. In the EU, Human SE cases are reported most commonly associated with the 
consumption of contaminated eggs and poultry meat (EFSA, 2008). 
 
1.4 Transmission of Salmonella 
 
Salmonella can be spread by horizontal transmission to other hosts including humans as well 
as vertical transmission, via an egg-associated (trans-ovarian) transmission to progeny. 
 
1.4.1 Horizontal transmission 
 
Chickens can get infected by Salmonella via various vectors in their surrounding environment 
and then horizontally transmit it to others. These vehicles include feed and water, as well as 
wild animals. In one flock, Salmonella can be transmitted via contaminated feces to 
individuals. Contaminated chickens become intestinal carriers, shedding the microorganism 
through their feces for long periods of time. In a study by Nakamura et al. (1993), shedding of 
SE persisted for more than 28 weeks after infection of newly hatched group-housed chicks in a 
seeder bird model. In the study of Van Immerseel et al. in 2004, both high dose (109 cfu) and 
very low dose (102 cfu) of SE resulted in persistent excretion for at least 18 weeks in chickens. 
Contamination will also occur between flocks as contaminated transport vehicle, introduction 
of the contaminated birds or flocks, and so on, may infect birds. Moreover, wild birds, 
mammals, rodents, insects etc. are generally regarded as the main reservoir for Salmonella in 
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the environment (Meerburg and Kijlstra, 2007). 
 
1.4.2 Vertical transmission 
 
The vertical transmission occurs when reproductive organs are infected with Salmonella by 
direct contamination of the yolk, albumen, eggshell membranes or eggshells before 
oviposition. This route was believed to be important in the large number of egg-associated 
outbreaks (Okamura et al., 2001a, b; Gantois, 2009).  
 
Salmonella is introduced to the egg from infected ovaries or oviduct tissue before the hen lays 
the egg (Keller et al. 1995). Salmonella can gain access to the peritoneal cavity, ovary and 
oviduct areas of an adult hen with resulting contamination of the structures of the egg, such as 
the yolk, membranes and shell, during ovulation and egg formation within the oviduct (Keller 
et al, 1995). Adult laying hens infected may carry the organism in their large intestines and 
shed it in their feces, which may lead to contamination of the eggshell surface then the 
contents of eggs. The eggshell structure provides several readily accessible sites, including 
shell surface, shell pore and the outer and inner shell membranes, for Salmonella to reside, 
often as a result of environmental contamination. This will lead to the laying of contaminated 
eggs, and these infected chicks will grow up to become pullets and subsequently lay 
contaminated eggs (Sanchez et al, 2002).  
 
However, research has shown that 0 to 0.6% of the eggs with infected contents laying by hens 
having contaminated reproductive tract, which indicated that there might be factors within the 
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eggs that control the pathogen before the eggs are laid (Barrow and lovell, 1991; Keller et al., 
1995; Gast, 1994; Gantois, 2009). While it the proportion of infected eggs laid by infected 
hens could be greatly different when layers got experimental infected, which implied that oral-
exposure doses of Salmonella Enteritidis for laying hens can significantly affect both the 
frequency and location of deposition of this pathogen inside eggs (Gast et al., 2013). Once in 
the egg, the albumin is not ideal to bacterial survival. The reproductive tract produces and 
incorporates into the albumen antimicrobial components that are growth restricting for 
Salmonella. The most well known are lysozyme and ovotransferrin. Lysozyme may affect 
integrality of the cell wall of Gram-negative bacteria by forming pores, and ovotransferrin 
may create an iron-deficient environment for bacteria to inhibit their growth and interact with 
the membrane and interfere with biological functions of the bacterial cytoplasmic membrane 
(Gantois et al., 2009). 
 
1.5 Infections of Salmonella 
 
1.5.1 Infections in human 
 
Most people are probably exposed to Salmonella from time to time, either from contaminated 
foods or from environmental sources. The incidence of Salmonella is especially high in infants 
and young children, elderly, and patients suffering chemotherapy and immunodeficiency, and 
this is because of either an immature immune protection or suppressed immune function 
(Sirinavin and Garner, 2000; Kendall et al., 2003). Under certain conditions, this exposure 
leads to clinical infection, subclinical infection or asymptomatic carriage.  
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When human are infected with non-typhoid Salmonella, they will have diarrhea (sometimes 
bloody). Stomachache, fever, nausea, and vomiting are the most classic symptoms of 
gastroenteritis. In most of cases, salmonellosis symptoms will develop within 24-48 hours 
after exposure. In some other situations, patients may be asymptomatic and symptoms develop 
as late as 10 days after exposure (Mølbak and Neimann, 2002; Onwuezobe et al., 2012).  
 
1.5.2 Infection in chickens 
 
Several factors can affect the susceptibility of poultry to Salmonella colonization. Young 
chicks are more susceptible to Salmonella infection and gut colonization from hatching to 96 
hours of age because of immature immune system (Bohez et al., 2007). The stress from 
environment, transport and other diseases also may result in weak resistance to Salmonella 
infection. In other cases, some feed additives, such as antimicrobials and anticoccidials, may 
interfere with the inner-balance by killing gut microflora without purpose, which intern to 
destroy the integrity of intestinal mucosal protection. Salmonella would then take place of 
these microflora and get chance to colonize on the intestinal wall to facilitate the infection 
(Bailey, 1988; Foley, 2011). 
 
Mortality rates in poultry infected with SE PT4 were 2% in broilers during the first 48 hours 
of life, with a cumulative mortality and morbidity rate of 6% and 20% respectively, at 5 days 
of age (McIlroy et al., 1989). Affected young chicks may exhibit symptoms including 
anorexia, adypsia, depression, ruffled feathers, huddling together in groups, reluctance to 
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move, drowsiness, somnolence, dehydration, white diarrhea and stained or pasted vents 
(Baskerville et al., 1992). Laying flocks are often clinically normal, despite the isolation of SE 
from fecal droppings, dust and litter (Hinton et al., 1989; McIlroy et al., 1989). However, 
clinical signs are sometimes found in laying hens. Salmonellosis in broilers due to ST 
infection has been characterized by growth retardation, blindness, twisted necks, lameness and 
mortality and cull rates that varied between 1.7% and 10.6% in flocks during the first 2 weeks 
of age (Padron, 1990). 
 
Post-mortem lesions seen in chicks affected with salmonellosis may consist of dehydration, 
emaciation, an unresorbed or poorly resorbed yolk sac, and infection of the yolk sac with 
sometimes presence of necrotic debris.  Lesions related to septicemia such as splenomegaly, 
hepatomegaly, necrotic foci and petechiation in the liver and spleen, various serositis such as 
airsacculitis, perihepatitis, pericarditis and peritonitis have been described in all type birds as 
well as lesions to the ovary and oviduct in mature birds.  Watery intestinal contents and 
reddened areas of the mucosal surface of the duodenum, ileum and colon, typhlitis, with or 
without bloodstained or inspissated cecal cores have been reported, (Wray and Wray, 2000). 
 
In newly hatched chicken, SE can cause diarrhea and septicemia with invasion and infection 
of a variety of internal organs including liver, spleen, peritoneum, ovary and oviduct (Lutful 
Kabir, 2010). When the animals become infected with SE, extensive interstitial edema of the 
lamina propria and the submucosa of the intestines can be observed within one day of 
infection, followed by a rapid influx of granulocytes and macrophages (Desmidt et al, 1996). 
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In this regard, the course of SE infection in young chicken resembles that in susceptible 
humans. 
 
2 PATHOLOGY AND VIRULENCE OF SALMONELLA 
 
Salmonella is orally taken up by the hen and enters the intestinal tract. Bacteria possess 
different strategies to attach and colonize the intestinal lumen are able to invade the intestinal 
epithelial cells. As a consequence, immune cells, more specifically macrophages, are attracted 
to the site of invasion and enclose the Salmonella bacteria. This allows the bacteria to survive 
and multiply in the intracellular environment of the macrophage. These infected macrophages 
migrate to the internal organs such as the reproductive organs. 
 
2.1 Pathogenesis 
 
2.1.1 Getting to the intestinal gut 
 
Salmonella is usually orally taken by hosts. Salmonella first need to pass the acidic 
environment of the proventriculus so that it can move into the small intestine. Thus bacterial 
resistance against these acidic conditions plays an important role in infection (Kwon and 
Ricke, 1998; Marcus et al, 2000). Two types of acid-tolerance systems have been described: 
one is activated on exposure to an acidic environment during log phase growth, which is 
regulated by the ferric uptake regulator (Fur) (Foster and Hall, 1996) and is activated by 
exposure to pH 5 with short life about 20 to 40 minutes (Rychlik and Barrow, 2005), and the 
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other one develops during stationary phase, which depends on the alternate sigma factor RpoS 
(Fang et al, 1992; Seshadri and Samuel, 2001). The log phase rpoS-dependent acid resistance 
also can be observed after at least 60 minutes of adaptation period (Rychlik and Barrow, 
2005). Besides, PhoPQ and OmpR are also pH-response regulators (Bang et al, 2002). PhoPQ 
is a two-component signal transduction system present in Salmonella. The phoPQ-dependent 
acid tolerance response mainly protects Salmonella in inorganic acid environment. OmpR is 
central to the stationary phase-inducible acid tolerance, and its activity is induced to protect 
Salmonella survival in organic acid environment (Rychlik and Barrow, 2005). 
 
2.1.2 Adhesion 
 
After its successful passage through the stomach and upon entering the gut, Salmonella has to 
counterbalance the intestinal peristalsis and to ensure its adhesion for gut colonization. 
Adhesion to host tissues is a crucial step during pathogenesis: the first tight contact between 
host and microbe is a prerequisite for triggering distinct processes like biofilm formation or 
protein translocation that may then be followed by entry into the host cell and later systemic 
dissemination.  
 
The various adhesion systems present in Salmonella have been organized into different 
categories. Fimbrial and non-fimbrial adhesins are the two major groups of adhesive structures 
(Soto and Hultgren, 1999), with the latter group including two adhesins (SiiE and BapA) from 
the type I secretion system (T1SS) and autotransported adhesins from the type V secretion 
system (T5SS). Additionally, several surface structures of Salmonella, whose main functions 
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are primarily not involved in adhesion, also contribute in part to the attachment and 
colonization of host tissues. These structures include flagellum, the Type III Secretion System 
(TTSS) and LPS. These factors will be described in the next section.  
 
2.1.3 Invasion 
 
Salmonella must be able to adhere to and invade the epithelial cell layer lining the intestine in 
order to cause enteritis and/or systemic disease. 
 
The primary sites of invasion are the Peyer’s patches, which contain specialized membranous 
epithelial cells (M cells) in the follicle-associated epithelium (FAE) that overlay aggregation 
of lymphoid cells. Experiments in mice suggest that bacterial entry and destruction of M cells 
play a major role in the invasion process in order to reach the Peyer’s patches (Jones et al, 
1994; Monack et al, 1996; Jensen et al, 1998). The M cells facilitate host colonization and are 
able to sample the bacteria from the lumen content and present it to the immune system. The 
FAE facilitating uptake of bacteria is helped by four features: low quantities of mucus which 
is associated with the absence of goblet cell, low concentration of secretary IgA (sIgA) since 
lacking of polymeric immunoglobulin receptors, and an inner glycocalyx as well as an 
irregular brush border (Jepson and Clark, 2001). Salmonella is capable of invading enterocytes 
as well as M cells, and dendritic cells (DC) and microphages have also been implicated in the 
transfer of Salmonella across the intestinal epithelium.  
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Invasion of the intestinal mucosa results in an extrusion of the infected epithelial cells into the 
intestinal lumen and a destruction of microvilli, which leads to a loss of absorptive surface. 
The invasion of epithelium causes structural damage to intestinal wall cells (Burkholder and 
Bhunia, 2009). Bacterial invasion of the M cells or enterocytes also elicits an acute 
inflammatory response in the host intestinal epithelium, characterized by the production of the 
proinflammatory cytokines, which stimulate the influx of polymorphonuclear leukocytes into 
the infected mucosa (Eckmann et al, 1993; Saarinen et al, 2002.). In addition, invasion of the 
M cells and enterocytes and the following inflammation may bring adverse consequences. Cell 
death and sloughing of the FAE provide new opportunities for bacteria to invade the 
submucosal tissues (Jepson and Clark. 2001).  
 
The molecular mechanisms by which Salmonella modulates the intracellular trafficking 
remain largely to be defined, but it has been demonstrated that Salmonella can invade non-
phagocytic cells through its type III secretion system (T3SS-1), which induces a Trigger entry 
process (Jantsch et al, 2011), which is characterized by dramatic cytoskeletal rearrangements 
and the apparition of large membrane ruffles at the bacterial entry site (Velge et al., 2012). 
However, it was demonstrate that SPI-1 facilitates systemic infection but is not essential for 
invasion and systemic spread of the organism in chickens (Desin et al., 2009), since 
Salmonella is able to induce Zipper entry system via outer membrain protein Rck to invade 
cells (Rosselin et al., 2010). The Rck invasin expressed on Salmonella outer membrane 
interacts with its receptor on the host cell membrane, leading the invading bacteria are tightly 
bound to the host cell membrane, and only minor cytoskeletal protein rearrangements are 
initiated by specific contact between bacterial ligands (invasin) and host cell surface receptors 
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(Velge et al., 2012). Zipper entry system is a T3SS-independent invasion mechanism, which 
implys that SPI-1 is not unique factor for Salmonella cell invasion any more (Rosselin et al., 
2010). 
 
2.1.4 Infection/dissemination 
 
The bacteria can be taken up by macrophages, survive and then be carried as engulfed bacteria 
to systemic sites through the lymphatic system (Richter-Dahlfors et al, 1997). Survival of 
Salmonella within macrophages is generally considered to be essential for the translocation of 
bacteria from the gut-associated lymphoid tissue to the liver and spleen (Gantois et al, 2009). 
 
Once Salmonella has breached the epithelial barrier, it comes into contact with cells of the 
reticuloendothelial system, in particular resident macrophages that are intimately associated 
with M cells. Salmonella can proliferate in epithelial cells and non-activated macrophages. 
The bacteria are demonstrated to primarily replicate in macrophages, as it is found in the 
lymphatic tissues and organs during systemic infection (Jantsch et al, 2011). 
 
It has reported that SPI-2 is essential for the intracellular survival and replication of the 
bacteria. SPI-2 carries genes that encode for a second Type III Secretion System (TTSS-2) that 
is structurally and functionally distinct from the TTSS that is encoded by SPI-1 mediating 
invasion (Jantsch et al, 2011). Via TTSS-2, Salmonella may deliver proteins into Salmonella-
containing-vacuoles or through the vacuolar membrane into the host cytosol. This process 
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influences intracellular trafficking and contributes to the intracellular survival of Salmonella in 
macrophages (Uchiya et al, 1999). 
 
After host cells invasion, Salmonella can survive and replicate within a modified phagosome 
known as the Salmonella-containing vacuole (SCV) with an active modification (Steele-
Mortimer, 2008; Jantsch et al, 2011). It is documented that the avoidance of phagolysosomal 
fusion is unlikely to be a major pathogenic strategy of Salmonella. Studies in various cell 
types also demonstrated that the vacuole acidifies; however, depending on the mechanism of 
host cell entry, vacuolar acidification may be delayed in both macrophages and epithelial cells 
(Jantsch et al, 2011). In addition, the ability of Salmonella to survive exposure to lysosomal 
contents is mediated by its resistance to antimicrobial peptides, nitric oxide, and oxidative 
killing, and these features are important for its survival within macrophages and to virulence 
(Jantsch et al, 2011). 
 
2.1.5 Metabolic adaptation 
 
During the various stages of an infection, Salmonella encounters a variety of environmental 
challenges, such as nutrient starvation, oxidative stress and digestive enzymes. Salmonella is 
equipped with a series of adaptive mechanisms that enable it to survive these challenges. 
Apart from the various tightly controlled Salmonella pathogenicity islands (SPI) that function 
at various stages of the infection, a sophisticated regulation of bacterial metabolism appears to 
exist. One group of genes that play a role in metabolic adaptation is the starvation stress 
response genes, called “starvation-stress response genes” (Spector, 1998). These genes encode 
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for metabolic functions that are required for Salmonella to survive in the starving host 
environment during infection and thus can be considered as determinants of virulence. The 
identification of genes that are required for bacterial survival at a certain stage of infection 
deserves more attention as they may provide opportunities to develop attenuated strains with 
vaccine potential. 
 
2.2 Virulence factors 
 
2.2.1 Salmonella Pathogenicity Island (SPI) 
 
Many virulences of S. enterica are encoded by genes on Salmonella Pathogenicity Island 
(SPI). At present, 12 different SPI have been described (Hensel, 2004). The major SPIs of SE 
include SPI-1, SPI-2, SPI-3, SPI-4 and SPI-5. SPI-1 and SPI-2 have been studied most 
frequently. Salmonella pathogenicity islands 1 and 2 (SPI-1 and SPI-2) each encode a 
specialized type III secretion system (T3SS) that enables Salmonella to manipulate host cells 
at various stages of the invasion/infection process (Winer et al., 2010). The SPI-1 encoded 
T3SS can induce cytoskeletal rearrangements resulting in the uptake of S. enterica even by 
host cells so that it is required for the transport of S. enterica proteins across the cytoplasmic 
membrane of a host cell into its cytosol (Kaniga et al., 1995). The effector proteins encoded 
within SPI-1 are translocated into the host cell cytoplasm through the secretion apparatus. In 
particular, AvrA, SipABCD, SopE, SopE2, SopB, and SopD are translocated into the host 
enterocyte by the secretion machinery encoded by SPI-1. These effector proteins orchestrate 
the cytosol changes that result in uptake of Salmonella. It is believe that SPI-1 is essential for 
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Salmonella invasion host cells until recent that some studies demonstrate that SPI-1 is not 
necessary for the cell invasion anymore but can facilitate the rapid host cell invasion (Desin et 
al., 2009). SPI-2 encoded T3SS is required for the transport of S. enterica proteins across the 
phagosomal membrane (Cirillo et al., 1998; Hensel et al., 1998) and increase intracellular 
survival (Hensel et al, 1995; Vazquez-Torres and Fang, 2001). Hensel et al. (1998) and Cirillo 
et al. (1998) have demonstrated that SPI-2 is required for survival in host phagocytes. 
Subsequent research by Vazquez-Torres et al. (2000) suggests that SPI-2 may interfere with 
trafficking of the NADPH oxidase to Salmonella-containing vacuoles thereby preventing 
phagocyte-dependent oxidative killing. It has been also recently suggested that SE SPI-2 T3SS 
facilitates invasion and systemic spread in chickens, although alternative mechanisms for these 
processes appear to exist for the systemic spread levels of SPI-2 mutants could match that of 
the wild-type strain (Winer et al., 2010). SPI-3 genes are involved both in gut colonization due 
to MisL-dependent fibronectin binding and intracellular survival due to high-affinity 
magnesium transport encoded by mgtABC (Smith et al., 1998; Dorsey et al., 2005). SPI-4 
genes are required for the intestinal phase of disease by coding for non-fimbrial adhesin 
(Morgan et al., 2004), and the genes localized in SPI-5 are co-regulated with either SPI-1 or 
SPI-2 genes and therefore code for effector proteins transported by either of these T3SS 
(Knodler et al., 2002). However, the vast majority of this information has been obtained in a 
mouse model and ST, and much less data are available for SE or poultry although poultry in 
particular represent major reservoirs of SE. 
 
2.2.2 LPS 
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LPS of Salmonella, which is made of lipid A, the core oligosaccharide chains and O 
polysaccharides, is a major component of the outer membrane and an important toxin that 
interacts with the host immune system to induce inflammation and produce septic shock, 
fever, and death.  
 
Salmonella can modulate the structure of the O-antigen as a means of dampening host innate 
immune responses, and an action that presumably enhances the microorganism’s ability to 
persist and survive in the host (Ernst et al, 2001). The lipid A has a potential biological 
activity that is able to cause pathophysiological effects, tells the endotoxic shock, 
pyrogenicity, complement activation, coagulation changes and hemodynamic changes. Lipid 
A contributes to the pathogen or toxic activity of Salmonella. LPS is considered a component 
that has the capacity to stimulate cytokine synthesis (Henderson et al, 1996). 
 
2.2.3 Flagellin 
 
Flagellin composes protein subunits of flagella. Flagellin is typically diphasic in Salmonella. 
The availability of two genetic systems (genes distantly located on the chromosome) 
expressing different flagellins could help the microorganism to survive the host’s defenses.  
 
Flagella exist in two forms termed antigenic phase 1 and phase 2 and H antigens are then two-
phase (Popoff, 2001). SE antigen H is called a single-phase (phase 1: g, m), while ST has both 
type of antigen H (phase 1: i and phase 2: 1,2). Research has shown that flagellin g, m is 
highly antigenic. This protein is extracted in relatively pure form from the surface of 
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Salmonella. Flagellin (g, m) is used commercially for the serological analysis of serogroup 
identification because the production of this antigen is relatively easy. This distinguishes the 
SE infection and those of other strains of Salmonella (McDonough et al, 1998). 
 
2.2.4 OMP 
 
OMPs interface the cell with the environment, thus representing important virulence factors 
with a significant role in the pathobiology of gram-negative bacteria and bacterial adaptation 
(Hamid and Jain, 2008). The OMPs of gram-negative bacteria are immunologically important 
because of their accessibility to the host defense system. OMPs (82.3 and 75.6 kDa) were 
shown to be involved in attachment of Salmonella Enteritidis to intestinal epithelial cell lines 
(Fadl et al., 2002). SE membrane usually contains three major proteins of the outer membrane: 
OmpC (36 kDa), OmpF (35 kDa) and OmpA (33 kDa). A Canadian study (Poppe et al, 1993) 
with 318 SE isolates primarily from poultry and their environment showed 35 of 36 strains 
had the same profile of OMPs (42, 40 and 37 kDa). The expression of OMPs in SE can be 
significantly influenced by conditions of growth of the bacterium (Chart et al, 1993). Chart et 
al. (1993) found that the expression of iron regulated OMPs: 74, 78 and 81 kDa was induces 
when SE is growing in trypticase soy broth containing ovotransferin. Recently, outer 
membrane protein of SE Rck was reported can induce a Zipper enter system to help the 
bacterial invasion to host cells (Rosselin et al., 2010). 
 
3 CHICKEN IMMUNE RESPONSES  
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Chicken immune system is divided into two types of immunity – innate and adaptive. Innate 
immunity such as physical barriers and chemical barrier prevents the entry of pathogens. 
Meanwhile, adaptive immunity takes over when innate immunity fails to stop an invading 
pathogen. Adaptive immunity involves targeted recognition of specific molecular features on 
the surface of a pathogen, resulting in a series of events intended to eliminate that pathogen 
and establish protection to subsequent challenges. Although innate immunity is effective, this 
response is normally unable to fight against pathogens and prevent disease completely. On the 
other hand, acquired immunity not only can protect birds against pathogens, but also will 
provide more rapid and effective protections when the host gets infected with the same 
pathogens again. Adaptive immunity can be further divided to humoral and cell-mediated 
immunity. 
 
3.1 Innate immune responses 
 
Innate responses are considered important in the earliest phases of microbial invasion, to 
rapidly limit the spread of the pathogen very rapidly until adaptive responses become 
mobilized to clear the infection. Also, the innate and adaptive responses are highly integrated. 
The earliest pathogen recognition events that occur in the body lead to recruitment and 
enhancement of innate responses, as well as activation of the adaptive immune system 
(Davison et al., 2008). 
 
3.1.1 Constitutive barriers 
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Innate immune responses are important in controlling the early phases of infection with 
Salmonella. When Salmonella is infected orally, it will enter gastrointestinal tract to try to 
attach and colonize the epithelial cells and in turn to cause further infection. In the 
gastrointestinal tract mucosa, there are several physical and chemical defenses to help to stop 
the bacteria. 
 
There is also mucus lining on the intestinal epithelium. It is a mixture of glycoproteins 
produced by goblet cells whose viscous slimy consistency can trap bacteria and prevents them 
from reaching the surface of the epithelial cells. In addition, mucosal cells are constantly being 
replaced and old cells are ejected into the lumen, which is also helpful to stop bacteria 
reaching and colonizing the intestinal epithelia (Salyers et al., 2011). Mucus also possesses 
proteins that have a certain antibacterial activity. One example is the lysozyme, which can 
digest the Gram-negative cell wall if breaches in the outer membrane are made by membrane-
disrupting substances, such as the bile salts found in the intestine. Another example is the 
lactoferrin, an iron-binding protein that sequesters iron and deprives bacteria of this essential 
nutrient.  
 
The epithelium lining the intestinal tract consists of tightly packed cells which are attached to 
each other by protein structures called tight junctions. The tight binding of epithelial cells to 
one another prevents bacteria from transiting through the epithelial layer. To get through the 
epithelium, bacteria must either take advantage of breaches caused by wounds or be capable of 
invading epithelial cells, passing between them or passing through them to get to underlying 
tissue.  
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Antimicrobial peptides (AMP) are important components of the natural defenses and have 
been isolated from most living organisms. They will form pores in the membrane of bacteria 
and fungi leading to cell death to eliminate the further infection. Defensins are toxic peptides 
isolated from most living organisms, and only β-defensins exist in chickens (Xiao et al., 
2004). They kill bacteria by forming pores in their membranes and collapsing the proton 
motive force that is essential for bacteria survival. In the crypts of the intestinal mucosa, 
defensins offer presumably protection to the intestinal stem cells, which divide constantly to 
replenish the intestinal mucosa to eliminate bacterial adhesion (Salyers et al., 2011). It was 
also reported that β -defensin antimicrobial peptides might play a role in intestinal epithelium 
and vagina immune responses against Salmonella Enteritidis (Derache et al., 2009; 
Anastasiadou et al., 2013).  
 
3.1.2 Heterophils 
 
Heterophils are the avian Polymorphonuclear leukocytes (PMN) that are an essential 
component of the innate immune system. Heterophils actually contribute to host resistance 
against Salmonella infection (Swaggerty et al., 2005). Heterophils in poultry are equivalent to 
the neutrophils in mammals and are important mediators of natural resistance during bacterial 
infections (Davison et al., 2008). Because of their early response and their ability to kill 
pathogens, heterophils are considered a biomarker for assessing the competence of innate 
immunity in poultry (Swaggerty, 2003). In chickens, heterophils accumulate in the propria 
mucosae of the caeca within 18 hours after an experimental infection with a SE field strain 
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(Van Immerseel, 2002). During infection, Salmonella can be rapidly detected and killed by the 
various functions of heterophils (Kogut et al., 1994; Kogut, 2001). Detection of bacterial Toll-
like receptors stimulates heterophil phagocytosis and oxidative burst (Kogut et al. 2001; 
Farnell et al. 2003) and induces expression of pro-inflammatory cytokines (Kogut et al. 2005). 
Antimicrobial substances contained in heterophil granules can be released through 
degranulation to kill phagocytized bacteria (He et al. 2005). It has also been implied that 
heterophils play a central role in protecting the host against colonization and invasion of 
intestine mucosa (Kogut et al., 1994; Van Immerseel, 2002).  
 
3.1.3 Phagocytes 
 
Phagocytes include immature dendritic cells, monocytes and heterophils that ingest and kill 
bacteria. They are able to defend the blood and tissue once the bacteria breach the epithelial 
surface successfully. When bacteria encounter the phagocyte, they are first engulfed by 
endocytosis into a phagosome. Fusion of phagosomes and lysosomes to form the 
phagolysosome releases toxic lysosomal enzymes and proteins that kill most bacteria. Debris 
from dead bacteria is then released by exocytosis (Salyers et al., 2011). The oxidative burst of 
phagocytosis activate products are reactive oxygen (ROI) and reactive derivatives of nitrogen 
(RNI) such as chloramines, hydrogen radicals, and the hydrogen peroxide. ROI are necessary 
to protect against Salmonella. These compounds kill bacteria very efficiently within 
macrophages (Raupach and Kaufmann, 2001). 
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Assessing the ability of heterophils and monocytes in phagocytosis revealed that heterophils 
phagocytose more SE than monocytes do (Stabler et al., 1994). In addition, heterophils can 
kill intracellular Salmonella, while the majority of non-opsonized Salmonella survive within 
monocytes. Therefore, heterophils are capable of killing bacteria more effectively than 
monocytes (Stabler et al., 1994; Swaggerty et al., 2005). 
 
3.2 Adaptive immune responses 
 
3.2.1 Antigen presentation 
 
B lymphocytes express surface immunoglobulin (Ig) molecules with great specificities for 
antigens, and T lymphocytes recognize processed antigens on antigen presenting cells (APCs). 
Upon binding of an antigen to B cells expressing surface immunoglobulin (Ig), cell division 
and clonal expansion ensue and Igs with identical antigen specificity are secreted from the 
differentiated B cells. In contrast, T cells only recognize small fragments of antigens in 
association with MHC molecules that have been processed by APCs (Lillehoj and Trout, 
1996).  
 
Immunization with antigens through the gut induces the production of local antibody and 
cellular responses. The nature of the antigen influences the mode of antigen uptaking, 
processing, presenting, and the type of APC. Dendritic cells, macrophages, and epithelial cells 
are representative of APCs in the gut. In addition, Peyer’s patches are critical to initiate 
antigen-specific immune response to pathogens capable of penetrating M cells, which may 
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pinocytose and phagocytose both soluble and particulate (e.g., viruses and bacteria) antigens 
in the lumen of the gut (Cerutti and Rescigno, 2008). The M cells can present antigen to 
underlying lymphoid cells, leading to the sensitization of lymphoid cells present in distinct T 
and B-cell zones in the PP (Lillehoj and Trout, 1996). 
 
3.2.2 Humoral immune response 
 
The humoral immunity mediated by antibodies produced by B cells. There are three classes of 
antibodies that are produced in the chicken after exposure to a pathogenic organism: IgM, IgY 
(IgG), and IgA (Lipman et al., 2005). IgY is detected after 5 days following exposure, peaks at 
3 to 3 1/2 weeks, and then slowly decreases (the method of antibody detection was not 
mentioned, while ELISA is widely used for antibody analysis) (Esatu et al., 2012). IgYs are 
the most important protective sera antibody in the chicken and is measured by most 
serological test systems. Tran et al. (2010) found that high titers of serum IgY could not be 
associated with reduction of intestinal SE burden after an experimental challenge. This 
suggested that during Salmonella infection, IgY protection might not as important as IgA 
protection. IgA and IgM are the predominant Igs in the local intestinal mucosa. IgM appears 
after 4-5 days following exposure to a disease organism and then disappears by 10-12 days. It 
is effective in elimination of microbes (Lillehoj and Trout, 1996). IgA appears after 5 days 
following exposure. Secretary IgA can prevent environmental antigen influxing into internal 
body compartments, neutralize viruses and microbial toxins, and prevent microbial pathogens 
adhering and colonizing mucosal surfaces, as well as facilitate antigen catch by binding to M 
cells (Lillehoj and Trout, 1996; Cerutti and Rescigno, 2008).  
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The B cells respond by producing antibodies after day 5 following bacteria exposure via 
macrophages. The lag period occurs because the B-cells must be programmed and undergo 
clonal expansion to increase their numbers. If the chicken is exposed a second time to the 
same disease, the response is quicker and a much higher level of antibody production occurs 
(memory immune responses) (Chalghoumi et al., 2009) which is the concept for vaccination. 
Antibodies do not have the capability to kill bacteria directly. To respond to bacterial 
infection, antibodies in serum need to activate the complement to mediate their antibacterial 
effect, which are opsonophagocytosis and direct bacterial lysis. In the mucosal surface, on the 
other hand, since IgA cannot activate the complement system, its major role is neutralization 
of antigens by binding to bacterial surface antigens and preventing the cells from attaching to 
their targets on epithelial cells. 
 
Because Salmonella is intracellular bacteria, antibodies are unlikely to protect the host against 
the intracellular stage of infection (Lillehoj et al., 1996). Cell-mediated response is therefore 
necessary to lyse infected cells. Only when the bacteria are released into the extracellular 
environment, the antibodies can then they participate in the elimination of bacteria (Erf, 2004). 
So, to fight Salmonella infection, cell-mediated immune response is more important. 
 
3.2.3 Cell-mediated immune response 
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For endogenous antigens or intracellular pathogens, the cell-mediated immunity is the 
functional aspect of the avian immune system that works to destroy the infected cell to expose 
pathogens then to kill them. 
 
Examples of actions by cell-mediated responses include activation of macrophages, cell lysis 
by cytotoxic T lymphocytes and natural killer (NK) cells, all mediated by cytokines released 
by T helper cells or other cells (Lillehoj and Trout, 1996). Cytokines are chemical messengers 
that coordinate the interactions between immune cells as one of their extensive functions. 
Cytokines are crucial stimulators of the initiation and maintenance of the immune response 
and play a role as effector molecules themselves to impact the duration and strength of the 
response (Kogut, 2000). 
 
T lymphocytes are the antigen specific cells in the cell-mediated immunity（CMI） response, 
capable of recognizing a wide range of pathogens. T lymphocytes are subclassified by surface 
markers and receptors. All T cells express a CD3 complex on their cell surface, independent of 
the T cell receptor presenting. T helper cells are typically identified by CD4 surface markers, 
serving primarily a regulatory role in adaptative immunity, both cell-mediated and humoral. T 
helper cells function to activate macrophages by secretion of cytokines and stimulate B cell 
growth and differentiation. Cytotoxic T lymphocytes (CTLs) can be identified by typically 
having CD8 on their surface and are important in lysis of intracellular pathogen infected cells 
and tumor cells (Moser and Leo, 2010). CTLs recognize foreign antigens in the context of 
MHC class I molecules and initiate the cyctotoxic effects, whereas helper T cells recognize 
antigens in association with MHC class II molecules and differentiate to Th1 and Th2 with the 
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effects of different cytokines, then in turn to stimulate the cytotoxic activation of macrophage 
and CTLs, and secrection of antibodies, respectively (Lillehoj and Trout, 1996; Tizard, 2009). 
 
NK cells have been postulated to play an important role as a primary host defense mechanism 
against tumors, bacteria, and viruses, as well as in the homeostasis of normal tissues 
(Herberman et al., 1978). The observation that chicken intestinal intraepithelial lymphocyte 
(IEL) contain NK cells that mediate spontaneous cytotoxicity (Chai and Lillehoj, 1988) 
suggests that NK cells may play an important role in local defense (Lillehoj and Trout, 1996).  
 
3.3 Local immune response for Salmonella 
 
The local immune system comprises T cells, a large number of B and plasma cells. The 
mucosa-associated lymphoid tissue (MALT) has special structures responsible for the first line 
of defense to the mucosal surface. With MALT pathogens are limited to adherence to the 
epithelium and intestinal colonization. Peyer's patches (PP) are more inductive site for IgA 
responses to pathogens and antigens ingested in the gastrointestinal tract (Lillehoj et al., 1996). 
 
The initiation of Salmonella infection appears originally in the mucosal surface where a 
humoral immune response usually occurs after infection. The immunoglobulin (Ig) is the 
predominant local secretory IgA, although the responses of IgY and IgM can also be observed. 
IgA is synthesized locally by plasma cells and is secreted through the mucous membranes and 
are present in secretions (Tizard, 2009). IgA acts like inhibiting the adhesion of 
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microorganisms to the surface of mucosal cells, thereby preventing the entry of 
microorganisms in body tissue (Basset, 2003).  
 
Ovary and oviduct are responsible for vertical transmission of pathogens. SE can be isolated 
from the mucosal surface of the oviduct (Hoop and Pospischil, 1993) and persists in 
reproductive tissues of naturally or experimentally infected chickens (Hoop and Pospischil, 
1993; Keller et al., 1995). Direct bacterial contamination of egg yolk or albumen Salmonella 
before shell formation following reproductive organs’ infection and bacterial penetration 
through the freshly laid eggshell (Barrow et al., 1991) were observed. It is interesting that the 
SE infection significantly induces the proliferation of B and IgA+ cells increased rapidly 
secretary IgA in the reproductive organs (ovary and oviduct) (Withanage et al., 1998; 
Withanage et al., 1999). A correlation between the increase of specific antibodies to SE and 
decrease the number of bacteria in the ovary and oviduct was observed (Withanage et al., 
1999) and the antibody titers of the oviduct titles were the same as those of the serum. 
Therefore, the local immunity in the oviduct is also very important. It has been reported 
oviduct is the site where maternal antibodies are transferred to eggs and the presence of IgA 
and IgM (egg white) and IgG (yolk) (Kovacs-Nolan et al., 2012). These antibodies could 
therefore provide newborns temporary protections before their own immune system fully 
developed.  
 
4 CONTROL AND PREVENTION PROGRAMS FOR SALMONELLA 
 
4.1 Controlling programs 
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4.1.1 The European Union (EU)  
 
The European Union (EU) has required member states to actively work to reduce and 
eliminate the presence of Salmonella in poultry flocks at all levels of production by setting up 
national control programs (European Union, 2008). These national programs target specific 
Salmonella spp. currently including SE, ST, S. Virchow, S. Infantis and S. Hadar (European 
Commission, 2010). Programs are unique to each state and to be all-inclusive, covering 
primary production, animal feed production and processing and preparation of foodstuffs for 
human consumption. The National Control Program (NCP) was introduced in the United 
Kingdom (UK) in 2007 and began in February 2008. The goal for breeders was to have no 
more than 1% of all breeding flocks test positive for Salmonella of public health significance 
(SE, ST, S. Virchow, S. Hadar and S. Infantis) by the end of 2009, and for broilers is to have 
less than 1% prevalence of SE or ST in all broiler flocks by the end of 2011 (DEFRA, 2008). 
Any samples testing positive for SE or ST in chickens must be reported and submitted for 
serotyping to the National Reference Laboratory (DEFRA, 2007a and 2008). Sampling 
protocols vary significantly for the different NCP programs. Chicken breeding flocks are 
tested three times before going into lay, and boot swabs or fecal samples are then collected 
every two weeks while in the flock is in lay. Official sampling occurs three times during the 
lay cycle or when a suspect positive case is detected. Any breeder flock testing positive for SE 
or ST is destroyed along with any eggs at the hatchery, and the hatchery is inspected to ensure 
that no spread of bacteria has occurred. If, however, the test is positive, the producer must 
make a plan with a veterinarian on how to reduce or eliminate the infection, but no chickens or 
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eggs are destroyed. Table egg chickens have to be tested once as day old chicks, once as 
pullets two weeks before they go into lay, and again at 22-26 weeks of age (DEFRA, 2007b). 
The hens are then tested every 15 weeks while in lay. If SE or S. Typhimurium is detected and 
confirmed in a flock, the eggs produced are required to be heat treated, and they will not be 
sold in the table egg market. 
 
4.1.2 The United States 
 
In the United States, the FDA produced a final rule for SE control in table eggs coming 
effective in July of 2009 (FDA, 2010). The prevention measures include buying pullets from 
SE monitored facilitie. SE monitored is defined as either a flock that is certified as US SE 
Clean or a flock between 14 and 16 weeks of age from which barn environmental samples are 
negative (FDA, 2010). The SE testing protocol for table eggs involves testing pullets at 14 to 
16 weeks of age, taking environmental samples from hen barns at 40 to 45 weeks of age and 
testing the environment of any flock that is molted 4 to 6 weeks after the molt is completed 
(FDA, 2009). Current policy for testing procedures involves producers submitting swabs of 
manure from each row/bank of each barn (FDA, 2008). If any of the samples tested positive, 
the producer is required to review the control protocols for any shortcomings and then must 
decide between diverting eggs to the breaker for the rest of the lifespan of the flock or 
submitting eggs for testing (FDA, 2010). Egg testing involves submitting a sample of at least 
1,000 eggs at two-week intervals for serological testing. If four consecutive tests come back 
negative no further testing must be done. If an egg sample in one test is positive, it is 
mandatory to divert all production to the breaker, with a producer only being allowed to return 
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to the table egg market provided four egg tests in a row are negative. Even then the producer 
must submit eggs for testing once a month for the duration of the life of that flock. 
 
4.1.3 Quebec 
 
In Canada, the controlling programs are varies among different provinces. The program in 
Quebec is considered unique in Canada, even in the entire North America. After a SE PT4 
outbreak in Northwest Quebec in 1996 which caused more than 150 patients to be infected and 
2 patients to die, the Quebec Egg Board decided to take steps to develop a comprehensive 
Food Safety Program involving all partners from the industry and various governmental 
agencies. To lower the risk of contamination, the producer must contract the services of 
professional exterminator to eliminate rodents or any other potential vector from the laying 
barn and must supply proof that the replacement pullets are SE negative, and must agree to 
have the environment of his laying barns tested by the Quebec Egg Board at intervals as 
determined in the program. Environmental samples are taken between 2-5 weeks and between 
12-16 weeks of age, and four tests during lay period of SE-free flock (environmental samples) 
are to be done. If a flock tests positive for SE, all the eggs will be destroyed and the flock will 
be depopulated. This SE surveillance program is developed and managed by producers and 
recognized by governmental agencies. It has the highest sampling frequency in North America. 
All these factors make the SE surveillance program in Quebec effective and unique in Canada 
and North America. 
 
4.1.4 Other provinces in Canada 
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To control Salmonella infection, all other provinces in Canada uses CHEQ program and SC-
SC (Start Clean, Stay Clean), SC-SCP (Start Clean, Stay Clean: Pullets) programz. CHEQ 
program (Canadian Hatching Egg Quality) is created by The Canadian Hatching Egg 
Producers (CHEP), which focuses primarily on biosecurity and proper egg handling and 
storage in broiler breeder operations as well as controlling pests, poultry health and cleaning 
and disinfecting protocols. “Start Clean, Stay Clean” (SC-SC) is the On Farm Food Safety 
Assurance Program (OFFSAP) developed for the Canadian egg industry. The stated aim of the 
SC-SCTM program is to prevent or reduce chemical and biological contamination in the 
production unit environment, the pullet, the hen and the egg. The SC-SCTM program works to 
mitigate food safety risks and focuses on preventative measures that can be applied to all egg 
production system scenarios. “Start Clean, Stay Clean: Pullets”, or SC-SCP for short, is an 
OFFSAP program that is based on HACCP principles. The program focuses on good 
management practices and critical control point issues associated with inputs and process steps 
in pullet production. In addition to these common programs, some provinces have their own 
unique features. In British Columbia, mandatory industry led biosecurity program for all 
poultry producers. Alberta has emergency response plan for all poultry producers in case of a 
disease outbreak. In Manitoba, egg farmers have egg quality program. In Ontario, Egg 
Farmers of Ontario (EFO) require vaccination of replacement pullets going to farms 
previously positive for SE and all SE positive pullet flocks to be slaughtered and voluntary 
supply flock testing program with follow up protocols including treatment and depopulation. 
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With increased consumer demands for safer products, the poultry meat industry should 
consider such a program and design strategies at all levels of production to suit this request. 
All steps of production must participate in a Salmonella control program if reduction is to be 
achieved. 
 
4.2 Biosecurity methods 
 
Good biosecurity measures are key components of Salmonella control programs to avoid the 
introduction of this pathogen onto the farm or to reduce or eliminate infection pressure. The 
importance of preventing the introduction of Salmonella through the purchase of animals 
cannot be overemphasized enough which is why the focus is placed on cleaning up and 
keeping Salmonella free breeding flocks. Hygienic measures should take into account animals, 
housing, management, pest control, vehicle disinfection, hand washing, and clothes and boot 
cleaning after each use (Snow et al., 2010; Berge and Wierup, 2012). 
 
The importance of cutting off introduction of Salmonella from the environment needs to be 
emphasized. This however extends beyond a fence, shower block and controlling the 
movement of people. The poultry house should be built to be easy for cleaning, immediate 
surroundings should be clear of vegetation and objects. Houses and hatchery area must be 
properly bird proofed and be able to keep rodents and other animals away from the houses. All 
feed used in poultry houses should be made in feedmills with good manufacturing or Hazard 
Analysis and Critical Control Point (HACCP)-based practices and monitored for Salmonella 
to minimize the risk of introducing Salmonella through contaminated feed. Drinking water 
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should come only from regularly tested sources treated to ensure purity. New and/or well-
disinfected equipments for eggs and newborn birds are also essential (Berge and Wierup, 
2012).  
 
Feed plays a crucial role in the control of Salmonella on two levels. First, the feed may 
potentially be an important vector to introduce Salmonella onto the farm. Proper control 
programs must, therefore, be in place at any feed manufacturing site, as well as on the farm to 
avoid ingestion of Salmonella by the animals, including preventing contamination by 
purchasing ingredients only from suppliers with a proven record of accomplishment with 
respect to Salmonelle control as well as control of dust, wild animals and moisture in fee 
manufacturing environment (Jones, 2011). Second, when animals are exposed to Salmonella 
through feed and other sources, feed composition, texture and supplements can be used to 
additionally minimize the risk of colonization and shedding of Salmonella. Thus, feed 
additives are recognized as a useful tool in prevention program (Berge and Wierup, 2012). 
 
Organic acids may have dual functions in reducing Salmonella contamination. First, they may 
reduce Salmonella load in the feed and, second, they may reduce the potential for infection 
and shedding in the animal. Short-chain fatty acids (SCFA), such as formic, acetic, propionic 
and butyric acids, have all been shown to down-regulate expression of invasion genes in 
Salmonella spp. (Van Immerseel et al., 2006). Research also showed that individual acids vary 
in their effect on Salmonella but, in general, medium-chain fatty acids are more effective than 
short-chain fatty acids (Johny et al., 2009) 
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Probiotics and prebiotics are also used as feed additives to help the young birds to combat the 
pathogenic enteric bacteria. The benefit actions of probiotics include regulation of intestinal 
microbial homeostasis, stabilization of the gastrointestinal barrier function (Salminen et al., 
1996), enzymatic activity inducing absorption and nutrition (Hooper et al., 2002; Timmerman 
et al., 2005), interference with the ability of pathogens to colonize and infect the mucosa (Gill, 
2003). Microorganisms used as probiotics in animal feed are mainly bacterial strains 
belonging to the genera Lactobacillus, Enterococcus, Pediococcus, and Bacillus, as well as 
microscopic fungi such as Saccharomyces. A prebiotic is a selectively fermented ingredient 
that allows specific changes, both in the composition and/or activity in the gastrointestinal 
microflora, that confers benefits upon host well being and health and it is well-established 
positive impact on the intestinal microflora (De Vrese and Schrezenmeir, 2008). Most 
identified prebiotics are carbohydrates and oligosaccharides; dietary carbohydrates such as 
fibers, are candidate prebiotics, but most promising are nondigestible oligosaccharides 
(NDOs) (Gaggla et al., 2010) 
 
Competitive exclusion (CE) cultures are a form of probiotic culture that is composed of a 
mixture of non-pathogenic bacteria typically found in the gastro-intestinal tract of adult birds. 
This treatment is generally used as a prophylactic measure aimed at increasing the resistance 
of young chicks to Salmonella (Mead, 2000), but it also can be used after antibiotic therapy to 
restore the normal microbiota (Seo et al., 2000). CE was initially developed and used in 
poultry production, where newly hatched chicks could be protected from subsequent 
Salmonella infections by accelerating the establishment of a complex, protective microflora 
(Nurmi et al., 1992; Schneitz et al., 1992) 
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Oral administration of chicken egg yolk immunoglobulin (IgY) has attracted considerable 
attention as a means of controlling Salmonella in poultry (Xu et al., 2011). It has been shown 
that specific IgY against Salmonella Enteritidis or Salmonella Typhimurium whole cells 
inhibits bacterial growth in liquid medium (Lee et al., 2002). In the study by Rahimi et al. 
(2007), 3-day-old chicks administered with purified yolk immunoglobulin (IgY) in drinking 
water and challenged with Salmonella Enteritidis, showed significantly lower fecal shedding 
and lower levels of Salmonella Enteritidis in the caecum. Non-immunized egg yolk powder 
has also been effective for eliminating and preventing Salmonella colonization in poultry. It is 
not clear the precise mechanism by which the egg yolk component prevents or eliminates 
infection; however, it can be attributed to its ability to prevent Salmonella from attaching and 
invading the intestinal epithelial cells, the first required site for infection (Kassaify and Mind, 
2004). 
 
4.3 Vaccines 
 
The criteria for an ideal vaccine against Salmonella infections in production system should 
include: (1) effective protection against both mucosal and systemic infection; (2) non-
pathogenic to animals and man; (3) efficacy in reducing intestinal colonization, and thus 
reducing environmental contamination, and egg infection; (4) compatibility with biosecurity 
measures; and (5) cost-effective application (Pritchard et al., 1978; Barrow, 1999). 
 
4.3.1 Inactive vaccines 
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Killed vaccines have been used to control host nonspecific Salmonella infections in poultry 
with very varying success. The protective immunity provided by killed pathogen vaccines is 
inferior because the killed pathogen stimulates mainly antibody production and is rapidly 
destroyed and eliminated from the host immune system, and relevant antigens are destroyed 
during vaccine preparation (Barrow, 2007). Killed vaccines generally fail to induce cytotoxic 
T cells (Foster and Spector, 1995) and secretory IgA responses, which are important for 
mucosal surfaces protection (Baay and Huis in 't Veld, 1993). In a previous studies in our lab, 
two commercial killed SE bacterin vaccines have been evaluated, and we have demonstrated 
that even if the humoral response and antibody (serum IgY and mucosal IgA) titers persisted 
throughout the production period after immunization, they were not sufficient to protect SE 
challenged hens from excreting the bacteria and these challenged hens still kept laying 
positive SE eggs at 55 and 65 weeks of age (Tran et al., 2009, not published). 
 
4.3.2 Attenuated live vaccines 
 
Attention has been paid to the development of avirulent vaccine strains of Salmonella. There 
is some evidence that such Salmonella strains are more immunogenic in mice and in poultry 
than killed or subunit vaccines are (Collins, 1974; Zhang-Barber et al., 1999). Live vaccines 
have been shown to be more effective in increasing lymphocyte proliferation in response to 
Salmonella Enteritidis antigens in laying hens. Although a number of different live Salmonella 
strains have been tested for their efficacy in experimental or semi-field studies, only a few are 
registered and commercially available for use in poultry in Europe (Vandeplas et al., 2010). 
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There are some important safety facts for Salmonella live vaccines, such as the investigation 
of reversion to virulence of attenuated vaccines or the potential that antibiotic resistance genes 
can be transferred to other microorganisms (EFSA, 2004). Information on the biological 
properties of the vaccine strains have to be given, the probability of recombination or genomic 
re-assortment with field or other strains should be considered. Genetic stability should also be 
considered as an important aspect of the safety of live Salmonella vaccines (Barbezange et al, 
2000) 
 
4.3.3 Subunit vaccines 
 
Protein-based subunit vaccines against SE have been studied in poultry. There are a lot of 
researches about OMPs as subunit vaccine candidates. Vaccines based on OMPs of SE induce 
a stronger antibody response than vaccines made from whole bacteria, which may indicate that 
OMPs contain the major immuno-dominant proteins of SE (Meenakshi et al, 1999). Hamid 
and Jain (2008) found that an OMP of ST with an apparent molecular mass of 49 kDa was 
highly immunogenic, which was capable to induce humoral and cell-mediated immune 
responses, and conferred 100% protection to immunized rats against challenge with very high 
doses (up to 100 times the 50% lethal dose) of ST. In another study, shedding of Salmonella 
Enteritidis in chickens decreased after immunized 9-week-old chickens with two outer 
membrane proteins (75.6 and 82.3 kDa) subcutaneously, followed by two boost 
immunizations with time intervals of 2 weeks interval (Meenakshi et al., 1999; Khan et al., 
2003). Immunization of either of the outer membrane proteins decreased cecal colonization 
about 1000-fold when the animals were orally infected with 8×108 CFU virulent SE strain 
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(Khan et al., 2003). Okamura et al. (2012) reported that after chickens were immunized with 
OmpA, serum IgY was induced even though while no decrease in cecal excretion and tissue 
colonization after SE challenge was observed. There have been a few studies involving 
Salmonella pathogenicity island (SPI)-1 and SPI-2 (Wisner et al., 2011; Desin et al., 2011). It 
has showed that a significant humoral immune response was induced after chickens were 
immunized with SPI-1 and SPI-2 proteins subsequently. Production of serum IgY and their 
transferring to egg yolk were observed. After a SE challenge, a reduction in the SE levels in 
the liver but not in the spleen was noticed. In addition, FliC, the flagellin antigen of 
Salmonella Enteritidis, also could induce a high IgY level in chickens after immunization. 
However, neither the proliferative response nor the interferon-gamma secretion of splenic cells 
upon stimulation with rFliC was induced (Okamura et al., 2012). In all these studies, protein 
antigens were given to chickens subcutaneously or intramuscularly. Although induction of 
serum IgY was generally observed, local mucosal IgA increase was hardly evaluated and 
protections against systemic bacterial colonization after orally SE challenge were various as 
well. Protections were not strictly correlated to level of serum IgY level which implies that the 
local immune response (IgA) plays an important role in protection against Salmonella 
infection. This might be because the initial site of entry and attachment of Salmonella is 
usually the mucosal surface once the bacteria are orally taken. The results could be different if 
these proteins were orally administered and delivered to the intestinal mucosa directly. 
Unfortunately, there has been very little work based on orally- administered protein subunit 
vaccine against SE in chickens. 
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In this project, five proteins have been chosen to be potential candidates for the new subunit 
vaccine against Salmonella Enteritidis and Salmonella Typhimurium in layers and breeders. 
They have been identified to be Glyceraldehyde-3-phosphate dehydrogenase, (GAPDH) 
Enolase, Lipoamide dehydrogenase (LpdA), DNA protection during starvation protein (Dps) 
et Elongation factor-Tu (EF-Tu). These proteins were selected from a previous study in our 
lab because that they are well conserved at the genetic level and well conserved with highly 
identical in both SE and ST. The surface expression of all these proteins has been reported, 
and the immunological functions of these proteins are already known in other species.  
 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (35.6 kDa) 
 
GAPDH is present in the outer membrane and cytoplasm and is highly antigenic. It is 
considered to be a strong vaccine candidate for bacterial infections (Park et al., 2011). 
GAPDH is a glycolytic enzyme catalyzing the oxidative phosphorylation of glyceraldehyde-3-
phosphate to 1,3-biphosphoglycerate in the presence of cofactor nicotinamide adenine (NAD) 
and of an inorganic phosphate molecule. Binding of surface GAPDH to host proteins or 
tissues was studied in bacterial and fungal species suggesting that adhesion of GAPDH with 
plasminogen and plasmin is probably part of the mechanisms contributing to bacterial invasion 
(Modun and Williams, 1999; Jobin et al., 2004; Egea et al., 2007). Bacterial surface GAPDH, 
expressing on the surface of pathogenic bacteria in general, has been observed mostly in 
Gram-positive species including Streptococcus species (Pancholi and Fischetti, 1992), 
Staphylococcus species (S. Epidermidis and S. Aureus) (Modun and Williams, 1999) and 
mycobacteria (Bermudez et al., 1996). Observation of surface GAPDH in enteropathogenic 
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Escherichia coli (EPEC) by Kenny and Finlay (1995) was the first report indicating that gram-
negative bacterial GAPDH is also secreted outside the cell. Surface expression of GAPDH in 
Neisseria Meningitidis and N. Lactamica has also been reported (Grifantini et al., 2002). Cell-
wall associated GAPDH also exist in fungal pathogens such as Candida albicans (Gil-Navarro 
et al., 1997) and Kluyveromyces marxianus (Fernandes et al., 1992). 
 
There is an increasing number of reports of immunogenic GAPDH from bacterial species 
published. Immunization with DNA vaccine encoding GAPDH of facultative intracellular 
bacteria Brucella abortus decreased spleen bacterial load of challenged mice (Rosinha et al., 
2002). Intra-peritoneal administration of purified recombinant surface GAPDH of Gram 
negative Edwardsiella tarda induced humoral protective response in Japanese flounders from 
disease and increased their survival rate (Liu et al., 2005). In Candida albicans, GAPDH is a 
highly immunogenic protein capable of inducing increased IgM responses in patients with 
systemic candidiasis or neutropenic patients (Gil-Navarro et al., 1997). Our laboratory has also 
already demonstrated the immunogenicity of ST glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) in experimentally and naturally infected pigs. Immunization with GAPDH 
encapsulated in PLGA microsphere could protect pigs against clinical signs associated with 
experimental infection by ST, and pigs were hardly showing fever and diarrhea after being 
challenged by 108 cells of ST (Quessy et al., 2007). 
 
Enolase (45.6 kDa) 
 
Enolase is found in surface of bacterial cell and catalyses the interconversion of 
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phosphoenolpyruvate and 2-phospho-D-glycerate during glycolysis. It is now clear that 
enolase is a multifunctional protein (Pancholi, 2001). One important property of eukaryotic 
and prokaryotic enolases is to bind plasminogen with great affinity (Miles et al., 1991; Redlitz 
et al., 1995; Pancholi and Fischetti, 1998). As a bacterial virulence factor, an important role of 
surface-expressed pneumococcal enolase in direct plasminogen-binding ability of S. 
pneumoniae has been found (Bergmann et al., 2001). As an immunogenic plasminogen 
receptor of Borrelia burgdorferi, Enolase released in outer membrane vesicles could be 
responsible for external proteolysis in the pericellular environment and have roles in nutrition 
and in enhancing dissemination of the bacteria (Toledo et al., 2012). Surface expression of 
Enolase has been previously found in different bacteria, including Streptococcus species 
(Bergmann et al. 2001), Aeromonas hydrophila (Sha et al., 2003), Borrelia burgdorferi 
(Toledo et al., 2012). Immunogenicity of Enolase in Streptococcus pneumonia and Candida 
albicans were demonstrated by its immuno-recognition with anti-enolase antibodies present in 
diseased patients’ sera (IgG) (Sandini et al., 1999; Whiting et al., 2002). Enolase also has been 
reported as an immunodominant antigen in the cell walls of Pneumocystis carinii (Fox and 
smullan, 2001).  
 
DNA protection during starvation protein (DPS) (18.7 kDa) 
 
The DNA-binding protein Dps that is generally regarded as cytoplasmic, and is found in many 
eubacterial and archaebacterial species, protecting DNA under a variety of stress conditions. It 
appears to protect cells from oxidative stress and/or nutrient-limited environment. Dps has 
been shown to accumulate during the stationary phase, to bind to DNA non-specifically, and 
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to form a crystalline structure that compacts and protects the chromosome. In a recent study, 
Dps was found significantly enriched in outer membrane fraction of Salmonella when bacteria 
were incubated under a phagosome-mimicking condition. This was the first report 
demonstrating that this protein is outer-membrane-localized in Salmonella (Brown et al., 
2012). The positive role of Dps-like protein in adhesion and virulence during bacterial 
infections such as Salmonella Typhimurium was observed by Haikarainen and Papageorgiou 
(2010). Dps is a known virulence determinant of Salmonella (Haikarainen and Papageorgiou, 
2010), but how it translocates to the outer membrane and its role(s) at the cell surface remains 
to be investigated. It also has been shown that Dps protects Salmonella from iron-dependent 
killing by hydrogen peroxide, promotes Salmonella survival in murine macrophages and 
enhances Salmonella virulence (Halsey et al., 2004). Interestingly, Dps was recently observed 
on the cell surface of Escherichia coli, where it may play a role in attachment to abiotic 
surfaces (Goulter-Thorsen et al., 2011). Dps also has been identified as an outer membrane 
protein involved in E. coli’s response to pH change and it was induced in acid condition (Wu 
et al., 2008). 
 
Lipoamide dehydrogenase (LpdA) (50.6 kDa) 
 
LpdA is a cytoplasm membrane-associated and classically involved in the conversion of 2-oxo 
acids to their respective acyl-CoA derivatives. It is also present in organisms that do not 
contain 2-oxoacid dehydrogenase complexes. For instance, in Escherichia coli, LpdA 
stimulates ATP-binding cassette transport of several carbohydrates, and ubiquinone-mediated 
transport of amino acids implicated in virulence (Hakansson et al., 2007; Smith et al., 2002). 
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In ST, it is reported that LpdA was induced (up to 11-fold) upon addition of 
bactericidal/permeability-increasing protein from human neutrophils (Qi et al., 1995). 
Recently, LpdA was identified as novel surface-exposed virulence factor of P.earuginosa for 
its contribution to survival of P. aeruginosa in human serum (Hallstrom et al., 2012). In 
Neisseria meningitidis, LpdA constitutes an immunogenic surface antigen (Exposito Raya et 
al., 1999). 
 
Elongation factor-Tu (EF-Tu) (43.3 kDa) 
 
EF-Tu is a cytoplasmic protein, which is involved in polypeptide elongation during protein 
synthesis, but EF-Tu has recently been reported to be surface-associated in Streptococcus 
pyogenes (Severin et al., 2007) and N. meningitidis (Kolberg et al., 2006; Williams et al., 
2007). Its roles as a bacterial adhesion and invasion for Pseudomonas aeruginosa, 
Mycoplasma pneumonia and Francisella tularensis have been reported (Kunert et al., 2007; 
Balasubramanian, et al., 2008; Barel, et al., 2008). Moreover, using serological proteome 
analysis, EF-Tu was identified as a seroreactive protein of Bacillus anthracis (Chitlaru et al., 
2007). EF-Tu also recently reported as a novel vaccine immunogen against Burkholderia 
infection since it is membrane-associated, secreted in outer membrane vesicles (OMVs), and 
immunogenic during bacterial infection in the murine model of melioidosis (Nieves et al., 
2010). 
 
Therefore, based on all the information obtained from previous researches, we assume that 
SE-derived GAPDH, Enolase, Dps, LpdA and EF-Tu are immunogenic and able to induce 
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immune responses and production of specific antibodies in eggs after immunizing hens with 
them. We will produce and purify these proteins and demonstrate their immunogenicities, in 
turn to prove that they are interesting to be further studied as potential candidates of a new 
subunit vaccine against Salmonella Enteritidis and Salmonella Typhimurium in laying and 
breeder hens. 
  
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
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Construction of protein expression vector 
 
The construction of protein expression vector was done at Laval University. Genes of interest, 
coding the selected Salmonella proteins i.e. GAPDH, Enolase, LpdA, Dps and EF-tu, were 
amplified by polymerase chain reaction (PCR) using genomic DNA from the field isolate 
Salmonella Enteritidis SHY-04-1540 as a template. Design of the primers was based on the 
already known complete genome of Salmonella enterica subsp. enterica serovar Enteritidis str. 
P125109 (NCBI Reference Sequence NC_011294.1), as the selected proteins were known to 
be well conserved among the various strains of Salmonella Enteritidis. For convenient cloning 
into the multiple cloning site of pQE-30 expression vector (Qiagen, Cat. 32149), two 
restriction sites were introduced in the primers, BamHI and HindIII, respectively in 5’ and 3’ 
of the genic sequences. Finally, in order to obtain fusion proteins in frame with N-terminal 
6XHistidine of pQE-30, the initiation codon of the gene sequences was removed. These 
recombinant plasmids allow the expression of fusion proteins, which then can be easily 
purified by nitrilotriacetic acid (NTA) affinity chromatography. The integrities of cloned 
sequences were checked by DNA sequence analysis.  
 
Transformation of E. coli M15 cells 
 
Back to our lab, E.coli M15 cells (QIAexpressionist, QIAGEN) were transformed with each of 
the five recombinant pQE30 vectors (conferring ampicillin resistance) according to the 
manufacturer’s instructions (QIAGEN). 
 
 
 
59 
 
High-level expression of proteins is possible in this system due to the presence of the T5 
promoter/lac operator transcription-translation for expression in E.coli. E.coli M15 cells 
contain the low-copy plasmid pREP4 that confers kanamycin resistance and constitutively 
expresses the lac repressor protein. 
 
Expression of the recombinant proteins 
 
Single colonies of the transformants were picked and transferred into 50 ml of LB media 
containing both ampicilin (100 μg/ml) and kanamycin (25 μg/ml) (Sigma-Aldrich 
Corporation, St. Louis, MO, USA). One extra culture was inoculated to serve as a non-induced 
control. The cultures were grown overnight at 37℃. Five hundred ml of pre-warmed medium 
(including antibiotics) were inoculated with 25 ml of the overnight cultures at 37℃ with 
vigorous shaking. When the absorbance at 600 nm was 0.6, IPTG (Isopropyl β-D-1-
thiogalactopyranoside) (Invitrogen Corporation, Burlington, ON, Canada) was added to a final 
concentration of 1 mM to induce expression of recombinant proteins. After the cultures were 
grown for an additional 4.5 h, cells were harvested by centrifugation at 5 000 g for 20 min at 
4℃, and the pellet was stored in -20℃. 
 
Purification of recombinant proteins 
 
The cell pellet was thawn for 15 min on ice and resuspended in 10 ml of lysis buffer (50 mM 
NaH2PO4, 300 mM NaCl, 10 mM imidazole (Fisher Scientific, Fair Lawn, NJ, USA), pH 8.0, 
filtered by 0.22 μm syringe filter), and lysozyme (Sigma-Aldrich Corporation, St. Louis, MO, 
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USA) was added to a final concentration of 1 mg/ml to destroy the bacterial cell wall and 
expose the proteins. After the lysozyme was dissolved completely, 60 μl Benzonase Nuclease 
(EMD Millipore Corporation, San Diego, CA, USA) was added and the contents were 
incubated on ice for 90 min with shaking. The lysate was then centrifuged at 10 000 g for 20 
min at 4℃, and the cleared supernatant was collected and filtered through a 0.22 μm syringe 
filter before applying it to affinity purification. For the following steps, two different methods 
were used to purity the proteins; Ni-NTA superflow resin from Qiagen, and Fast protein liquid 
chromatography (FPLC) 
 
1. Purification with QIAexprss Kit Type IV (Qiagen, Catalog No. 32149) 
Four milliliter of the supernatant obtained above was mixed with 1 ml the 50% Ni-NTA slurry 
by gentle shaking at 4℃ for 1 h. the supernatant/Ni-NTA mixture was loaded into a column, 
and the column flow-through was collected. Then, the column was washed twice with 4ml of 
wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0), and the wash 
fractions were kept for SDS-PAGE analysis. The 6xHis-tag recombinant protein was eluted 
from the resin four times with 0.5 ml elution buffer (50 mM NaH2PO4, 300 mM NaCl, 500 
mM imidazole, pH 8.0). The recombinant protein was analyzed by SDS-PAGE as described 
later in this chapter. 
 
2. Purification by Fast protein liquid chromatography (FPLC) 
Ni/NTA affinity purification was performed on an AKTA Xpress FPLC system using 1 ml 
HisTrap HP columns (GE Healthcare Bio-Sciences AB, Uppsala, Sweden). Columns were 
equilibrated with lysis buffer, the lysate loaded and the columns washed by lysis buffer until 
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the absorption of post-column flowthrough returned to base levels. Bound proteins were eluted 
with a linear gradient of imidazole elution buffer (50 mM NaH2PO4, 300 mM NaCl, 1 M 
imidazole, pH 8.0, filtered by 0.22 μm syringe filter), from 1% to 50% elution buffer, i.e. from 
10 to 500 mM imidazole. Weakly bound contaminating proteins typically eluted at 30-60 mM 
imidazole, the peak maximum of 6xHistidine tagged proteins was between 80 and 150 mM 
imidazole. Samples were taken at various time points and loaded on SDS-PAGE gels to 
evaluate the purity of target recombinant proteins. 
 
Immunization of laying hens 
 
Eighteen Specific Pathogen Free (SPF) White Leghorn hens from the Canadian Food 
Inspection Agency Ottawa Laboratory (Ottawa, ON, Canada) were received at 14-week of 
age. They were separated into 6 groups (n=3 birds/group), individually wingtagged for 
identification purposes, put in separate cages and fed ad libitum a Salmonella free commercial 
feed (first growth then layer diets). Feces samples of all birds before immunization were 
collected weekly for bacteriological examination to confirm Salmonella-free status of laying 
hens. They received 3 intramuscular injections in the breast muscle at 16, 20, and 28 weeks of 
age, respectively. Group 1 was treated as the control group and injected (IM) with 0.5 ml PBS 
and 0.5 ml FIA (Freund’s incomplete adjuvant) (Sigma-Aldrich Corporation, St. Louis, MO, 
USA) each time, and groups 2 to 6 were injected (IM) with 50 μg of each recombinant protein 
in 0.5 ml PBS and 0.5 ml FIA, respectively. Starting with the first egg laid, all eggs were 
collected daily and stored at 4℃ for future extraction of IgY (yolk) and IgA (white) as well as 
for following ELISA tests until 35 weeks of age when the trial was terminated. All the birds 
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were bled at 35-week-old before they were sacrificed, and blood samples were centrifuged at 5 
000 g for 10 minutes at room temperature. Serum samples were recovered and conserved at -
20℃ for ELISA testing. 
 
Extraction of antibodies from egg white and yolk 
 
1 Extraction of egg white antibodies 
 
A PEG-based Ig isolation method described by Hamal et al. (2006) was modified for 
antibodies extraction from the egg white. Briefly, the eggshell from the narrowed end was 
broken, and the egg white was allowed to run into a Falcon tube by gently inverting the egg to 
facilitate the flow of egg white. Twice the volume of PBS (one tablet dissolved in 200 ml 
water yields 0.01 M phosphate buffer) (Phosphate Buffered Saline Tablets, Fisher Scientific, 
Fair Lawn, NJ, USA) was added to the egg white collected, and the contents were mixed 
thoroughly by shaking. Pulverized Polyethylene glycol 6000 (PEG6000) (Sigma-Aldrich 
Chemie GmbH, Steinheim, Germany) was added to make a final concentration of 4.7% 
(wt/vol) and mixed thoroughly until the PEG6000 was completely dissolved. The mixture then 
centrifuged at 14,000 g for 10 min at room temperature. After centrifugation, the clear 
supernatant containing the Ig was collected, aliquoted, and stored at -20℃ for the following 
analysis. 
 
2 Extraction of egg yolk antibodies 
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A chloroform-based method described by Polson (1990) was used for Ig extraction from the 
egg yolk. After the egg white was taken, the egg yolk was allowed to run into a 50 ml Falcon 
tube, and the volume was noted. Twice the volume of PBS (0.01M, the same as described 
above) was added, and the contents were mixed thoroughly by vortex. An equal volume of 
chloroform (Sigma-Aldrich Corporation, St. Louis, MO, USA) was added, and the contents 
were mixed vigorously to produce a thick emulsion. After centrifugation (16 300 g, 20 min, 
room temperature), the mixture separated into 3 distinct layers. The watery phase on the top 
containing the immunoglobulins was collected, aliquoted, and stored at -20℃ until the 
following analysis. 
 
SDS-PAGE and Immunoblotting procedure 
 
SDS-PAGE followed by immunoblotting were used to prove immunogenicity of these 
recombinant proteins. Protein samples and molecular weight markers (Amersham High-Range 
Rainbow Molecular Weight Marker, GE Healthcare Bio-Sciences Corporation, Piscotaway, 
NJ, USA) were diluted in sample buffer (0.5M Tris, pH 6.8, 2% sodium dodecyl sulphate 
(SDS), 10% glycerol, 5% mercaptoethanol). Appropriate quantity of each protein (see results) 
was then loaded into 10% Bis-Acrylamide (Fisher scientific, FairLawn, NJ, USA) separating 
gels. Gels were run at room temperature in running buffer (25mM Tris, 0.2M glycine, 0.1% 
SDS) at 100V/10min and then 200V until the dye front reached the bottom of the gel cassette. 
After SDS-PAGE, proteins were electrophoretically transferred to nitrocellulose membranes 
(Bio-Rad Laboratories (Canada) Ltd., Mississauga, ON, Canada) using transfer buffer 
(0.125M Tris-base, 0.1M glycine) by running at 100 V for 1 h. The membranes were blocked 
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in Tris-buffered saline (TBS) and 2% (wt/vol) skim milk powder (Smucker Foods of Canada 
Co. Markham, ON, Canada) for 1 h at room temperature and then incubated 2 h with serum in 
the blocking buffer (TBS containing 2% (wt/vol) skim milk powder). After five washes for 5 
minutes each in TBS, the blots were incubated 1 h at room temperature with anti-chicken IgY 
(IgG) (whole molecule)-peroxidase produced in rabbit (Sigma-Aldrich Canada Ltd, Oakville, 
ON, Canada). After being washed five times, the blots were developed by incubation in a 
solution containing H2O2 (Fisher Scientific, FairLawn, NJ, USA) and 4-chloro-1-naphtol 
(Sigma-Aldrich Corporation, St-Louis, MO, USA) for 20 min in the dark. 
 
At first, the immunoblot was achieved as follows: mixed antisera against SE from immune 
layers (naturally infected chickens and vaccinated plus challenged) were used as primary 
antibody and anti-chicken IgG was used as secondary antibody with sera from naive chickens 
as the negative control. This protocol did not give satisfactory results even after numerous 
repetitions. So we decided to produce antibodies directly against each protein from eggs 
obtained from immunized hens with each recombinant protein. These antibodies were then 
used as primary antibody with sera from eggs of naive hens as the negative control, and the 
secondary antibody was the same anti-chicken IgG. Whole-cell proteins of SE, ST and E.coli, 
and OMPs of SE and ST also were used, which had been prepared in our lab as described 
before (Arockiasamy and Krishnaswamy, 2000; Tran et al., 2010). The various results are 
described in Results’ chapter. 
 
ELISA tests for specific IgY and IgA levels 
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The levels of the anti-GAPDH, anti-Enolase, anti-LpdA, anti-Dps and anti-EF-Tu IgY (in egg 
yolk and serum) and IgA (in egg white) were determined using Chicken IgG and IgA ELISA 
Quantitation Set (Bethyl Laboratories, Montgomery, TX, USA) respectively, following the 
manufacturer’s instruction. The samples were analyzed in duplicate. IgY and IgA extracted 
from naive layers were used as the experimental negative control. Each plate had its own set 
of standards (3.12 to 200 ng/ml for IgY; 15.625 to 1000 ng/ml for IgA). Reagents and buffers 
were prepared in our laboratory following the specifications of the manufacturer (Bethyl 
Laboratories, Montgomery, TX, USA). The working dilution of detection antibody used was 
1: 5,000 for specific IgY and 1:1 for specific IgA to ensure the effectiveness of the results.  
 
Briefly, flat-bottomed 96-well polystyrene plates (Nunc-Immuno Plates Maxisorp, Inter Med, 
Denmark) were coated with 20 μg/ml of each recombinant protein for 1 h. Non-specific 
binding was avoided by incubation with blocking buffer (50 mM Tris, 0.14 M NaCl, 5% skim 
milk powder, pH8.0) for 30 min. After washing 5 times with washing buffer (50 mM Tris, 
0.14 M NaCl, 0.05% Tween 20, pH8.0), 100 μl of each diluted sample was added to each well 
and incubated 1 h at room temperature. After 5 washes, the plates were incubated with 100 μl 
of HRP conjugated chicken IgG detection antibodies (Bethyl Laboratories, Montgomery, TX, 
USA) diluted at 1:75,000 or HRP conjugated chicken IgA detection antibodies (Bethyl 
Laboratories, Montgomery, TX, USA) diluted at 1:50,000. After washing, samples were 
incubated with 3,3′,5,5′-Tetramethylbenzidine (TMB) (Bethyl Laboratories, Montgomery, TX, 
USA) for 15 min, then the reaction was stopped using ELISA stop solution (Bethyl 
Laboratories, Montgomery, TX, USA) after 15 min. The plates were read at 450 nm using an 
EL 800 universal microplate reader (Bio-Tek Instruments Inc., Winooski, VT, USA) and KC 
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junior software (Bio-Tek Instruments Inc., Winooski, VT, USA). A standard curve describing 
the relation between the concentration of standards and their absorbance values was generated 
for each plate, and the antibody concentration of each sample was expressed as micrograms 
per milliliter or nanogram per milliliter. Additional calculations were carried out to determine 
the total amount of these antibodies per egg yolk (10-15 ml) and per egg white (20-25 ml). 
 
• Calculation formula for the determination of egg yolk IgY concentration 
Each yolk was diluted in twice the PBS volume before IgY extraction, and the work dilution 
of each extracted sample was 1:5000 for ELISA. So the final contration of IgY in yolk is: 
  
 
• Calculation formula for the determination of egg white IgY concentration 
Egg white from each egg was diluted in twice the PBS volume before IgA extraction, and 
samples after extraction had no more dilution for ELISA. So the final contration of IgA in egg 
white is: 
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Production and purity of recombinant proteins 
 
The N-terminal hexahistidine-tagged proteins were overexpressed in E. coli using standard 
procedures (see Materials and Methods). At first, our purification of produced proteins started 
using the Qiagen procedure (QIAexpress Kit Type IV，QIAGEN Inc.). The results showed 
that although overexpression of each protein was obviously present, their purity was not 
satisfactory due to the presence of numerous contaminant bands as shown with SDS-PAGE 
(see Figure 1 showing GAPDH and EF-Tu as examples). Since it is crucial to achieve as the 
highest purity level as possible for each recombinant protein for the next experiments, it was 
decided to use FPLC. FPLC results showed much higher purity for each protein with much 
less unwanted bands appearing on the gel (see Figure 2). After purification of the recombinant 
proteins by FPLC, in order to evaluate their integrity and conservation of the His-tag, an 
analysis of purified proteins by Anti-His Immunoblotting was done (see Figure 3). 
 
Immunogenicity of recombinant proteins 
 
First, to prove immunogenicity of these recombinant proteins, mixed antisera against SE from 
immune chicken (naturally infected chickens and vaccinated plus challenged) were used as 
primary antibodies and anti-chicken IgG was used as secondary antibodies in a western-blot 
analysis, with sera from naive chickens as the negative control. Results revealed that this 
mixed antisera had difficulty to recognize each recombinant protein except for GAPDH (see 
Figure 4). Because these results were repeatedly obtained, we decided to directly evaluate, in 
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the chicken, the production of specific antibodies against each protein. For that, we immunized 
laying hens, and verified if specific antibodies could be produced in the derived eggs. 
 
Five groups of hens were injected with 50 μg of GAPDH, Enolase, LpdA, Dps and EF-Tu 
respectively and the sixth group was immunized with only PBS as the experimental negative 
control group. First, eggs were laid when the birds reached 21 weeks of age. Eggs were 
collected from 21 to 35 weeks of age at which the layers were euthanized. The egg yolk IgY 
was extracted from eggs using a chloroform-based method (see Material and Method). These 
IgY were then used in an immunoblotting analysis to test the recognition of interesting 
recombinant proteins as well as OMPs and whole-cell proteins of SE, ST and E. coli (see 
Table 1). Results showed that there were specific recognitions between antibodies and each 
recombinant protein and that some corresponding antigens were present in OMPs and whole-
cell proteins of different bacterial strains. Non-specific IgY from hens in control group (non-
immunized hens) was used as experimental negative control. For this control, recognition 
between non-specific IgY and each protein was not detectable (see Figures 5 to 9). 
 
Evaluation of immune response 
 
To achieve this part, ELISA was used to detect the concentration of IgY in yolk and IgA in the 
egg white during the 3 injections period. IgY in the sera was also examined prior to 
euthanasia. 
 
1 Egg yolk specific IgY levels 
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The levels of specific IgY from egg yolk were examined every week during the laying period 
for each hen. Generally, the specific IgY level increased and peaked in the 2nd to 3rd week 
after each injection, then decreased afterward. It tended to stabilize after the 3rd injection. 
Results also showed that in the stable phase after the 3rd injection, IgY levels against 
GAPDH, Enolase and Dps (> 1 000 μg/ml) were higher than levels of IgY against LpdA and 
EF-Tu (< 1 000 μg/ml) (see Figures 10 to14). 
 
2 Sera specific IgY levels  
 
Sera specific IgY levels were evaluated when hens were 35 weeks of age prior to euthanasia. 
Specific IgY levels were slightly lower in the serum compared to egg yolk lgY levels at the 
same age in individual bird. Also, IgY levels in the serum against GAPDH, Enolase and Dps 
(> 1 000 μg/ml) were higher than those against LpdA and EF-Tu (< 1 000 μg/ml) (see Figure 
15). This observation was similar to egg yolk specific IgY levels.. 
 
3 Egg white Specific IgA level 
 
Specific IgA levels from egg white were examined weekly during the laying period for each 
hen. For GAPDH, Enolase and Dps groups, the titers of specific IgA were undetectable until 
the 3rd immunization, and the range of IgA titers was 90-180 ng/ml (see figures 16 to18). For 
groups of LpdA and EF-Tu, the titers of specific IgA were almost undetectable during the 
entire laying period following immunizations (data not shown). 
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Table 1.  Bacterial strains used in assessment of recombinant proteins immunogenicity 
Bacterial strain Group specificity identification 
Origin of bacterial strain 
analysis 
Salmonella Enteritidis D SHY-04-1540 LEAQ 
Salmonella Typhimurium B SHY-2009-03429 LEAQ 
Escherichia coli Pathogenic ECL 14668 EcL 
Escherichia coli Non pathogenic ECL 16142 EcL 
LEAQ: Laboratoire d’épidémio-surveillance animale du Québec, Canada; EcL: The Reference 
Laboratory for Escherichia coli, Québec, Canada. 
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Figure 1. SDS-PAGE of recombinant GAPDH and EF-Tu purified by Ni-NTA matrix 
(Qiagen kit). Lane 1: Molecule weight marker (kDa); Lanes 2-4: three different purification 
batches of GAPDH (9 μg of protein per well); Lanes 5-7: three different purification batches 
of EF-Fu (7 μg of protein per well). These batches of GAPDH and EF-Tu were purified with 
the Ni-NTA matrix from Qiagen Kit.   
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Figure 2. SDS-PAGE of recombinant proteins purified by FPLC. Lane 1: MW marker 
(kDa); Lane 2-6s: GAPDH, Enolase, LpdA, EF-Tu, and Dps, respectively (5 μg of each 
protein per well). 
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Figure 3. Anti-His Immunoblotting Analysis of Purified Recombinant Proteins. Western 
blot with anti-His as primary antibody shows the His-tag conservation and expected molecular 
weights of FPLC purified recombinant proteins. Lane 1: MW marker (kDa); Lanes 2-6: 
GAPDH, Enolase, LpdA, EF-Tu, and Dps, respectively (5 μg of each protein per well). 
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Figure 4. Fluorescent western blot analysis with antisera against SE from immune layers. 
Lane 1: Molecule weight marker (kDa); Lane 2: GAPDH (5μg); Lane 3: Enolase (5μg); Lane 
4: LpdA (5μg); Lane 5: EF-Tu (5μg). The arrow points possible band of GAPDH. Primary 
antibody : antisera against SE from immune layers (1/1 000); secondary antibody : anti-
chicken IgY (IgG) (Sigma-Aldrich) (1/10 000). 
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GAPDH 
 
 
 
 
Figure 5. Immunoblotting analysis with specific IgY against recombinant GAPDH.  
A Dot Blot specific IgY against recombinant GAPDH (a) and negative antibody from control 
group (b). 1-3: recombinant GAPDH: 1μg, 5μg and 10μg, respectively; 4: whole-cell proteins 
of SE; 5: randomly chosen negative control: EF-Tu (10μg).  
B.Western Blot with specific IgY against recombinant GAPDH. Lane 1: MW marker (kDa); 
Lanes 2&3: recombinant GAPDH: 1μg and 5μg; Line 5&7: OMPs of SE and ST, respectively; 
Lanes 4, 6, 8&9: whole-cell proteins of SE, ST, E. coli 14668 and E. coli 16142, respectively. 
Line 10: experimental negative control, using negative antibodies from non-immunized layers 
and recombinant GAPDH.  
B 
b 
a 
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Enolase 
 
 
 
Figure 6. Immunoblotting analysis with specific IgY against recombinant Enolase.  
A Dot Blot with specific IgY against recombinant Enolase (a) and negative antibody from 
control group (b). 1-3: recombinant Enolase: 1μg, 5μg and 10μg, respectively; 4: whole-cell 
proteins of SE; 5: randomly chosen negative control: Dps (10μg).  
B.Western Blot with specific IgY against recombinant Enolase. Lane 1: MW marker (kDa); 
Lanes 2&3: recombinant Enolase: 1μg and 5μg; Line 5&7: OMPs of SE and ST, respectively; 
Lanes 4, 6, 8&9: whole-cell proteins of SE, ST, E. coli 14668 and E. coli 16142, respectively; 
Line 10: experimental negative control, using negative antibodies from immunized layers and 
recombinant Enolase. 
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Dps 
 
 
 
Figure 7. Immunoblotting analysis with specific IgY against recombinant Dps.  
A Dot Blot with specific IgY against recombinant Dps (a) and negative antibody from control 
group (b). 1-3: recombinant Dps: 1μg, 5μg and 10μg, respectively; 4: whole-cell proteins of 
SE; 5: randomly chosen negative control: LpdA (10μg).  
B.Western Blot with specific IgY against recombinant Dps. Lane 1: MW marker (kDa); Lanes 
2&3: recombinant Dps: 1μg and 5μg; Line 5&7: OMPs of SE and ST, respectively; Lanes 4, 
6, 8&9: whole-cell proteins of SE, ST, E. coli 14668 and E. coli 16142, respectively; Lane 10: 
experimental negative control, using negative antibodies from non-immunized layers and 
recombinant Dps.  
a 
b 
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LpdA 
 
 
 
 
Figure 8. Immunoblotting analysis with specific IgY against recombinant LpdA.  
A Dot Blot with specific IgY against recombinant LpdA (a) and negative antibody from 
control group (b). 1-3: recombinant LpdA: 1μg, 5μg and 10μg, respectively; 4: whole-cell 
proteins of SE; 5: randomly chosen negative control: Enolase (10μg).  
B.Western Blot with specific IgY against recombinant LpdA. Lane 1: MW marker (kDa); 
Lanes 2&3: recombinant LpdA: 1μg and 5μg; Line 5&7: OMPs of SE and ST, respectively; 
Lanes 4, 6, 8&9: whole-cell proteins of SE, ST, E. coli 14668 and E. coli 16142, respectively; 
Lane 10: experimental negative control, using negative antibodies from non-immunized layers 
and recombinant LpdA. 
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EF-Tu 
 
 
Figure 9. Immunoblotting analysis with specific IgY against recombinant EF-Tu.  
A Dot Blot with specific IgY against recombinant EF-Tu (a) and negative antibody from 
control group (b). 1-3: recombinant EF-Tu: 1μg, 5μg and 10μg, respectively; 4: whole-cell 
proteins of SE; 5: randomly chosen negative control: GAPDH (10μg).  
B.Western Blot with specific IgY against recombinant EF-Tu. Lane 1: MW marker (kDa); 
Lanes 2&3: recombinant EF-Tu: 1μg and 5μg; Line 5&7: OMPs of SE and ST, respectively; 
Lanes 4, 6, 8&9: whole-cell proteins of SE, ST, E. coli 14668 and E. coli 16142, respectively. 
Line 10: experimental negative control, using negative antibodies from non-immunized layers 
and recombinant EF-Tu. 
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GAPDH 
 
Figure 10. Quantification of specific IgY against recombinant GAPDH in egg yolk of 
laying hens during post-immunization period analyzed using chicken IgG ELISA 
quantitation set. Data shows the concentration of yolk specific IgY from laying hens, tagged 
as #4(♦) and #6(■), immunized 3 times with recombinant GAPDH. Two arrows stand for the 
time of 2nd and 3rd immunization, respectively. #5 was a poor layer and was not included in the 
results. 
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Enolase 
 
Figure 11. Quantification of specific IgY against recombinant Enolase in egg yolk of 
laying hens during post-immunization period analyzed using chicken IgG ELISA 
quantitation set. Data shows the concentration of yolk specific IgY from laying hens, tagged 
as #7(♦), #8(■) and #9(▲), immunized 3 times with recombinant Enolase. Two arrows stand 
for the time of 2nd and 3rd immunization, respectively. 
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Dps 
 
Figure 12. Quantification of specific IgY against recombinant Dps in egg yolk of laying 
hens during post-immunization period analyzed using chicken IgG ELISA quantitation 
set. Data shows the concentration of yolk specific IgY from laying hens, tagged as #13(♦), 
#14(■) and #15(▲), immunized 3 times with recombinant Dps. Two arrows stand for the 
time of 2nd and 3rd immunization, respectively. 
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LpdA 
 
Figure 13. Quantification of specific IgY against recombinant LpdA in egg yolk of laying 
hens during post-immunization period analyzed using chicken IgG ELISA quantitation 
set. Data shows the concentration of yolk specific IgY from laying hens, tagged as #10(♦), 
#11(■) and #12(▲), immunized 3 times with recombinant LpdA. Two arrows stand for the 
time of 2nd and 3rd immunization, respectively. 
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EF-Tu 
 
Figure 14. Quantification of specific IgY against recombinant EF-Tu in egg yolk of 
laying hens during post-immunization period analyzed using chicken IgG ELISA 
quantitation set. Data shows the concentration of yolk specific IgY from laying hens, tagged 
as #16(♦), #17(■) and #18(▲), immunized 3 times with recombinant EF-Tu. Two arrows 
stand for the time of 2nd and 3rd immunization, respectively. 
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Figure 15. Comparision of specific IgY in egg yolk and serum. Data shows that the 
concentration of specific IgY in egg yolk and serum at 36 week of age prior to euthanasia. The 
dark column and the light column stand for IgY from yolk and serum, respectively. Each 
number stands for one hen, and three hens per group. #1 and #5 were poor layers so they were 
not included in the results. For the control group, mixed 5 recombinant proteins (2 µg for each 
protein) were used, and no recognition signal between IgY and proteins was detected.  
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GAPDH 
 
Figure 16. Quantification of specific IgA against recombinant GAPDH in egg white of 
laying hens during post-immunization period analyzed using chicken IgA ELISA 
quantitation set. Data shows the concentration of specific IgA in white of each egg from 
laying hens, tagged as #4(♦) and #6(■), immunized 3 times with recombinant GAPDH. The 
arrow stands for the time of 3rd immunization. The specific IgA in the egg white was not 
detectable before the 3rd immunization. #5 was a poor layer and was not included in the 
results. 
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 Enolase 
 
Figure 17. Quantification of specific IgA against recombinant Enolase in egg white of 
laying hens during post-immunization period analyzed using chicken IgA ELISA 
quantitation set. Data shows the concentration of specific IgA in white of each egg from 
laying hens, tagged as #7(♦), #8(■ ) and #9(▲ ), immunized 3 times with recombinant 
Enolase. The arrow stands for the time of 3rd immunization. The specific IgA in the egg white 
was not detectable before the 3rd immunization.  
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Dps 
 
Figure 18. Quantification of specific IgA against recombinant Dps in egg white of laying 
hens during post-immunization period analyzed using chicken IgA ELISA quantitation 
set. Data shows the concentration of specific IgA in white of each eggfrom laying hens, 
tagged as #13(♦), #14(■) and #15(▲), immunized 3 times with recombinant Dps. The arrow 
stands for the time of 3rd immunization. The specific IgA in the egg white was not detectable 
before the 3rd immunization 
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Choice of candidate proteins 
 
According to results of a previous study in our lab, five candidate proteins have been chosen 
and were identified as: 1- Lipoamide dehydrogenase (LpdA) (EC 1.8.1.4), 2-Enolase (EC 
4.2.1.11), 3 - Elongation factor-Tu (EF-Tu), 4 - Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) (EC 1.2.1.12), 5- DNA-binding protein from starved cells (Dps). 
 
The selection of candidate proteins was based on their biological and immunological 
characters.  The immunological functions of these proteins have already been reported in 
different species including bacterial, and fungi (as described in the Literature Review). These 
proteins are well expressed and conserved at the genetic level in both SE and ST (the gene 
encoding each of these proteins is found with high identity (>99%) in SE and ST based on 
Genebank, NCBI). In our previous research, antibodies against these proteins were detected in 
layers that were naturally infected with SE, as well as in vaccinated and challenged layers. The 
surface expression of all these proteins has been reported (as described in the Literature 
Review). These proteins are functionally involved in DNA and RNA activities, or in center 
metabolism and energy production. In addition, they have been reported as virulent factors 
associated with bacterial adhesion and invasion to the host cell during the infection. 
Interestingly, Dps is able to protect the bacterial DNA in certain starving environments.  
 
Production and purification of selected recombinant proteins 
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Affinity tags are highly efficient tools when they are used with recombinant DNA techniques, 
which allow for a minor modification of proteins of interest leading to efficient detection, 
characterization and purification. The most widely used affinity tags for recombinant proteins 
purification is the polyhistidine tag. It is frequently used because of its low immunogenicity 
and small size. In addition, many proteins function with the polyhistidine tag positioned at 
either the N- or C-terminus, and purification methods can be carried out under both native and 
denaturing conditions (Young et al., 2012). The genes of selected recombinant proteins of this 
project were cloned in pQE30 vectors, which allowed a 6xhis-tag was installed at the N-
terminal of recombinant proteins. There are various advantages of placing a tag at the N-
terminal end, such as an efficient translation from initiation sites of pQE30 and this tag also 
can be removed easily (Sachdev and Chirgwin, 1998).After overexpressions by induction with 
IPTG, affinity-purification of these recombinant proteins was achieved with the use of Ni-
NTA, which exhibited high affinity for adjacent histidine residues.  
 
For this protein purification, we used a batch procedure described by QIAGEN at first. This 
procedure entails binding the protein to a Ni-NTA resin in solution and then packing the 
protein-resin complex into a column for the washing and elution steps. Since imidazole 
competes with his-tag to bind Ni-NTA, the washing step was achieved by twice volume of 20 
mM imidazole to the bacterial lysate. Single concentration of imidazole in small volume of 
washing buffer could not wash out all the unwanted proteins because these nonspecific 
binding proteins with various numbers of consecutive histidine residues have different binding 
strength with Ni-NTA matrix and various concentrations of imidazole are necessary to remove 
them. From our previous SDS-PAGE result (see Figure 1), there were a lot of non-targeted 
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proteins (additional bands) appearing with recombinant proteins. Recombinant proteins with 
poor purity are not optimal to be used, because the contaminants might interfere with 
specificity of all further detection and evaluation, both in vitro and in vivo. This is why we 
finally decided to use FPLC to perform the purification. Therefore, different gradients of 
imidazole were used to wash out as many as possible of unwanted proteins slowly and 
efficiently before the elution of target proteins. Because imidazole would compete with his-tag 
to bind Ni-NTA, different gradients of imidazole were used to remove as many unspecific 
binding proteins as possible and elute targets proteins with high purity at the end of the 
process (Kuo and Chase, 2011). Purified proteins used in our later experiments still contain a 
6xhis-tag, which was believed to be too small to interfere with the structure and function of 
the recombinant proteins as discussed before.  
 
Dps showed two bands after purification, a finding similar to that of Hanna et al. in 2008. 
According to results of SDS-PAGE and immunoblot with anti-His, it implies that the upper 
band seemed to be recombinant Dps with his-tag (see Figures 2 and 3) and the other one might 
be degradations resulting from the various steps of expression and fractionation (Hanna et al., 
2008). The relatively high salt concentration (300 mM NaCl) in buffers used during 
purification procedure might be the crucial reason for these degradations according to 
Stephani et al. (2003), who reported the degradation of Dps in vitro after its isolation from 
bacteria. Surprisingly, for the other proteins, no degradation bands after FPLC purification 
were detectable. This could imply that they might be resistant to the experimental reagents 
used in the procedure in order to maintain their integrities. Indeed, there is little information 
regarding their degradation during purification previously reported. 
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Immunogenicity of selected recombinant proteins 
 
GAPDH, Enolase, LpdA and EF-Tu were reported previously as immunogenic in other 
species including bacteria, fungi and parasite while there was little information about 
immunogenicity of Dps as discussed before. In the current study, their immunogenicities in SE 
and ST are of the higher interest.  
 
The evaluation of immunogenicity of selected proteins was achieved by immunoblotting. 
First, we assumed that if these proteins conserved in both SE and ST were immunogenic, they 
would be recognized by the antibody generated against these serovars. So the antisera from 
layers immunized with SE were used as primary antibody to detect their immuno-reactions 
with selected proteins. Unfortunately, specific recognition between antibody and selected 
proteins could not be efficiently displayed (data not shown). To resolve this problem, we 
decided to boost the sensitivity of the immunoblot, and then a high sensitive fluorescent 
western-blot with signal exposed on X-ray film was performed (Faoro et al., 2011). Except 
GAPDH, the other recombinant proteins were undetectable as well as many non-specific 
bands were visible (see Figure 4.). There are many possible reasons for this. One could be the 
low purity of proteins. These proteins were isolated from E. coli, which has numerous proteins 
in common with Salmonella Enteritidis. When these common proteins were not removed 
effectively, they tended to interfere with the result by reacting with antibodies. Another reason 
could be the various quantities of specific antibodies against each selected protein contained in 
antisera. The antibodies contained in the antisera included not only antibodies against selected 
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proteins, but also antibodies against many other SE whole cell proteins. So the quantities of 
antibodies against each selected protein might not be enough to have clear and convincing 
results to demonstrate their immunogenicity. The result also implied that quantities of specific 
antibodies for each protein might be various in this mix antisera and that only antibodies 
against GAPDH were present in sufficient quantities for specific recognition. Moreover, other 
facts might be potentially involved as well, such as GAPDH could be more immunogenic than 
other proteins so GAPDH might be able to generate more antibodies than other proteins, or 
avidities of different specific antibodies were various. After numerous repetitions with all the 
modifications of condition parameters without any better result, we decided to change the 
method and tried to produce antibodies in vivo against selected proteins directly. This is why 
laying hens were immunized intramuscularly (IM) with selected proteins respectively, then 
egg yolk IgY was extracted and specificities of these antibodies were later analyzed with 
western-blot. We assumed that if our selected proteins were immunogenic, they should be able 
to stimulate immune responses, and to induce antibodies against each of them. To our 
satisfaction, our new western-blot results supported this hypothesis. It showed that these yolk 
IgYs were able to recognize each recombinant protein we produced (Figures 2 to 6). 
 
The inoculum (1 ml) was administered to the hens intramusculary at 2 sites on the pectoral 
muscle. The dose of antigen (50 µg) was chosen on the basis of various similar procedures 
devoted to production of specific egg yolk antibodies against antigenic proteins. With the 
same conditions (protein, IFA as adjuvant, and IM injection), it appears that a range of 10 µg – 
100 µg of protein could produce sufficient amounts of specific IgY antibodies to be identified 
(Khan et al, 2003; Erhard et al, 2000).  
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We also found that these antibodies could recognize each protein conserved in whole-cell 
proteins and OMPs (outer membrane proteins) of SE and ST, the only exception being Dps 
that was not detected in OMPs (see Figure 7). This result was in accordance with a previous 
report on GAPDH, Enolase, LpdA and EF-Tu as bacterial surface-expressed proteins; this 
later study also reported that these proteins could be expressed on surface of SE and ST. This 
finding is important because the induced antibodies might find and bind to these surface-
expressed proteins in order to eliminate infection and neutralize bacterial virulence. In 
previous researches, all these five proteins, including Dps, were reported to be able to be 
expressed on cytoplasmic membrane. Dps is a DNA-binding protein, and when bacteria are 
suffering from some severe adverse environment conditions and stress, Dps is expressed in 
large quantity to protect the bacteria from the oxidative stress and limited nutrients (Martinez 
and Kolter, 1997). We assumed that Dps might appear in OMPs in large quantity produced 
when cells are stressed based on study of Brown et al in 2012, which implied that Salmonella 
outer membrane might be enriched with Dps in a phagosome-mimicking condition. Since our 
OMPs were extracted from bacterial cell growing under suitable conditions, Dps might not be 
expressed on the outer membrane or in a quantity not sufficient to be detected.  
 
According to data of Genebank, all these proteins are highly identical in SE, ST and E. coli, so 
all the selected proteins of SE and ST should be recognized in whole-cell proteins of E. coli. 
This finding of cross reactivity suggested that antibodies induced by proteins of SE and ST 
might be able to recognize and eliminated E. coli infection, which is also a common pathogen 
in chicken.  
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Hens and egg production 
 
In this experiment, 18 Special-pathogen-free (Salmonella free) White Leghorn hens arrived at 
14 weeks of age, and were separated by cages individually marked with the numbers #1 to 
#18. Feces were collected and detected weekly to ensure that hens remained Salmonella free. 
For almost hens, the first eggs were laid at around 21 weeks of age, and the production for 
each normal bird was around 5 to 7 eggs per week. Among these birds, #1, #5 and #6 were 
exceptions for different behaviors. Bird #1 had difficulty to get feed (no matter the feed 
texture presented) so it developed more slowly than other birds and gained less weight. It laid 
no egg during the experiment, which was possibly because of malnutrition. For bird #5, its 
antibody levels in both yolk and serum were significantly low (at least less than half of other 
birds). This humoral immune deficiency sign could be caused by various factors such as 
inherent deficiencies or bacteria or virus infections. For bird #6, its laying was delayed for 
about 10 weeks compared to the others, and started at 31 weeks of age; otherwise it had 
normal physical development and antibody levels. Because of these behaviors, Birds #1 and 
#5 were not included in the results while bird #6 was included due to its normal antibody 
levels obtained.  
 
Egg antibody production 
 
The commercially available chicken IgY ELISA quantitation set and chicken IgA ELISA 
quantitation set were used to assess antibody (IgY and IgA) produced in eggs and sera. The 
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highlight of this method was that it is a quantitative protocol so that it can provide an idea 
about antibody quantities. In addition, these sets are widely used in recent researches for 
antibody quantifications (Natsuda et al., 2010; Rocha et al., 2011; Nandre et al., 2012; Nandre 
et al., 2013). Because of all these advantages, this was the optimal protocol to be used. The 
working dilutions of our sample antibodies (1:5 000 for IgY and 1:1 for IgA) were decided by 
the effectiveness of result readings and calculating according to the manufacturer’s 
instructions (Bethyl Laboratories). The concentration of IgY in egg yolk was much higher than 
that of IgA in egg white, and the optimal dilution of samples was necessary to select to ensure 
the OD of final ELISA plates reading was comparable to standard values (as described in 
Materials and Methods) and detectable. This is why we used working dilutions of 1:5 000 and 
1:1 for IgY and IgA respectively. 
 
Specific egg yolk IgY levels 
 
IgY is recognized as an important maternal antibody that is selectively secreted from the 
circulation of the hen into the egg yolk and then absorbed across the yolk sac membrane into 
the embryonic circulation. It can protect newborn chicks against pathogens before 
development and maturity of their own immune system one to two weeks after hatch. It has 
been reported that the amount of total IgY in yolk ranges from 60 to 150 mg/yolk of which 3-
15 mg/yolk are antigen-specific (Kovacs-Nolan and Mine, 2012). Our results are in 
accordance with these data, with quantities of specific yolk IgY ranging from 4 to 17 mg/yolk. 
Yolk specific IgY levels induced by recombinant proteins showed a similar trend during the 
laying period (Figures 7 to 11). IgY levels increased after each injection, and reached a peak 
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2-3 weeks later, then decreased afterward. Levels were also more stable after the 3rd injection 
than those after the 2nd injection. Also we found that the amount of IgY in the yolk was 
correlated with the IgY concentrations in serum, as reported in previous work (Figure 12) 
(Kramer and Cho, 1970; Loeken and Roth, 1983; Hamal et al., 2006). 
 
Specific egg white IgA levels 
 
During egg formation, IgA induced by local immunity is deposited into the egg white in the 
oviduct as maternal antibodies. Its major function in the newly hatched chick, as a protective 
Ig in the alimentary tract, is to provide protection to young chicks until their own immune 
response become fully effective (Hamal, 2006; Kovacs-Nolan and Mine, 2012). During the 
whole experimental period, specific IgA induced by GAPDH, Enolase and Dps were not 
detectable until 1 to 2 weeks after the 3rd injection, and the levels ranged from 90 to 180 μ
g/ml (Figures 13-15), whereas, the specific IgA against LpdA and EF-Tu were almost 
undetectable during the whole trial time (data not shown). When compared together, the 
results showed specific antibody levels in yolk, serum and white appeared positively 
correlated among each other, and GAPDH, Enolase and Dps might have induced higher 
antibody levels that LpdA and EF-Tu.  
 
Because IgA is a major mucosal immunoglobulin and because its presence in the egg is due to 
mucosal secretions deposited into the egg white, the finding of specific IgA against GAPDH, 
Enolase and EF-Tu in the egg white after immunization would suggest that these three 
proteins might be able to stimulate mucosal immune response. This is a very valuable finding 
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for the development of an oral vaccine because if specific IgA against these proteins could be 
produced even by intramuscular administration, then it is expected that these proteins could 
induce a strong local mucosal immune response if oral administration is used, which is the 
optimal route to stimulate local mucosa immune response.  
 
Although the quantities of specific IgA were very low, this was the first time that specific IgA 
against bacterial proteins in egg white are observed,. In the past, the research about specific 
IgA from egg white has been very scarce, and there is hardly any study about egg white 
specific IgA against protein antigen. For virus antigen, Hamal et al. in 2006 tried to test 
specific IgA against Newcastle disease virus (NDV) and infectious bronchitis virus (IBV) in 
egg white but no satisfactory result was obtained. 
 
Salmonella Enteritidis and Salmonella Typhimurium being enteric pathogens, mucosal 
immunity (secretory IgA) plays a fundamental role in the protection against Salmonella 
infection (Hackett 1993). In this study, because our objective was to assess the 
immunogenicity of selected recombinant proteins, as the birds were inoculated with the 
selected proteins intramuscularly, we did not determine the mucosal immune response 
directly. We assumed that immunization of layers with the selected recombinant proteins by 
routes that induce a strong mucosal immune response such as oral administration might 
potentially increase the production of mucosal antibody (secretory IgA). Although the present 
study indicated that these selected candidate proteins were immunogenic and can stimulate the 
production of specific antibodies in eggs, both IgY and IgA, the results should be considered 
preliminary because of the administration route and the lack of a large study size. Therefore, 
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future experiments should involve a larger group of birds and replicates, as well as direct 
assessment of mucosal immune response such as secretory IgA evaluation, especially after 
determining the suitable route for administering the selected proteins in layers. 
  
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
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In conclusion, we found the satisfactory techniques to produce and purify recombinant 
proteins, and also demonstrated immunogenicity of these selected recombinant proteins and 
their potentials to be a new subunit vaccine against SE and ST in chickens in this research. 
 
First, pQE30 vector is useful tool to install a 6xhis tag to the N-terminal of each protein, then 
after overexpression in E.coli with affection of IPTG, these recombinant proteins would be 
purified by FPLC using the specific affinity between his-tag and Ni-NTA resin column. These 
gained proteins were with high purity and well conserved the His-tag, which suggest that 
techniques we used to produce and purify recombinant proteins are ideal to achieve a 
satisfying result. 
 
Because antibodies collected from hens injected with recombinant proteins could recognize 
each of them with immunoblot tests, we demonstrated that these proteins could induced a 
specific antibody response in hens which demonstrates the immunogenicity of these proteins. 
Moreover, these specific antibodies induced by recombinant proteins could also recognize 
specific antigens in whole-cell proteins and OMPs of SE and ST, which implied a possible 
recognition between these antibodies and bacterial cells. The results also suggested that 
antibodies induced by proteins of SE and ST might be able to recognize and eliminated E. coli 
infection, which is also a common pathogen in chicken, due to the existence of the cross 
reaction between antibodies against recombinant proteins and E.coli whole-cell proteins. 
 
In addition, we evaluated the titer of specific antibodies induced by proteins in blood (IgY), 
egg yolk (IgY) and egg white (IgA) using ELISA. We found that GAPDH, Enolase and Dps 
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induced and maintained higher level of specific antibodies than LpdA and EF-Tu in blood, egg 
yolk and white. Also, specific IgA against LpdA and EF-Tu were not detectable during our 
study. IgA is a very important antibody produced by local mucosal immune response which is 
also a really significant aim about the oral vaccine against SE infection; therefore it is very 
interesting to find that GAPDH, Enolase and Dps could even induce IgA production by 
intramuscular injection, which is not the optimal administration route for mucosal antibodies 
production. Based on these findings, we demonstrated that these five selected recombinant 
proteins, which are GAPDH, Enolase, Dps, LpdA and EF-Tu, were immunogenic since they 
were capable to stimulate the production of specific antibodies in vivo (blood, egg yolk and 
egg white) after immunization of layers. However, their abilities of stimulating local mucosal 
responses and the production of local sIgA via oral administration are not proved directly and 
need to be further studied.  
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